[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "llama-2-7b-chat-hf_response": "Acrokeratosis paraneoplastica is also known as:\n* Acrokeratosis paraneoplastic syndrome\nNote: These terms are synonyms, and both refer to the same medical condition."
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "llama-2-7b-chat-hf_response": "Weaver syndrome and Sotos syndrome are both rare genetic disorders that are characterized by overgrowth and developmental delays, but they have some differences in their clinical features and genetic causes.\nSimilarities:\n* Both Weaver syndrome and Sotos syndrome are caused by mutations in genes that are involved in cell growth and division.\n* Both disorders result in overgrowth and developmental delays, with children typically reaching milestones later than their peers.\n* Both disorders can also cause intellectual disability, although the severity of this condition can vary widely between individuals.\nDifferences:\n* Genetic cause: Weaver syndrome is caused by mutations in the SMC1 gene, while Sotos syndrome is caused by mutations in the NSD1 gene.\n* Age of onset: Weaver syndrome typically becomes apparent at birth or in early childhood, while Sotos syndrome can be diagnosed at any age but is usually apparent by the time a child is 2-3 years old.\n* Physical features: While both disorders can cause overgrowth and developmental delays, the physical features of Weaver syndrome are more variable and can include a range of skeletal, cardiovascular, and other abnormalities. Sotos syndrome typically has more consistent physical features, including a distinctive facial appearance, short stature, and heart defects.\n* Intellectual disability: While both disorders can cause intellectual disability, Sotos syndrome is often more severe and can result in significant cognitive impairment.\nIn summary, while Weaver syndrome and Sotos syndrome share some similarities, they are distinct genetic disorders with different genetic causes, age of onset, physical features, and severity of intellectual disability."
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "llama-2-7b-chat-hf_response": "The JASPAR (Joint Annotation and Scanning Project for Assessment of Regulatory Elements) database is a collection of transcription factor binding site (TFBS) matrices that predict the presence and strength of TFBSs in the human genome. Here are the releases of the JASPAR database:\n1. JASPAR Release 1.0 (2002): This was the first release of the JASPAR database, which contained TFBS matrices for 10 transcription factors and covered approximately 20% of the human genome.\n2. JASPAR Release 2.0 (2004): This release added TFBS matrices for an additional 10 transcription factors, bringing the total number of TFs to 20. The coverage of the genome was also increased to approximately 40%.\n3. JASPAR Release 3.0 (2007): This release included TFBS matrices for 30 transcription factors and covered the entire human genome.\n4. JASPAR Release 4.0 (2010): This release added new features such as improved TFBS prediction and the ability to download matrices in a variety of formats.\n5. JASPAR Release 5.0 (2013): This release included TFBS matrices for 40 transcription factors and improved prediction algorithms.\n6. JASPAR Release 6.0 (2016): This release added new features such as the ability to predict TFBSs in non-coding regions and improved prediction algorithms.\n7. JASPAR Release 7.0 (2019): This release included TFBS matrices for 50 transcription factors and improved prediction algorithms.\n8. JASPAR Release 8.0 (2022): This is the latest release of the JASPAR database, which includes TFBS matrices for 60 transcription factors and improved prediction algorithms.\nPlease note that these releases are not the only ones available, and the database is constantly being updated with new data and improved methods."
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "llama-2-7b-chat-hf_response": "The KP4 protein is a protein encoded by the KP4 gene of the poxvirus. The KP4 protein is a key regulator of the poxvirus life cycle and plays a crucial role in the replication and pathogenesis of the virus. The KP4 protein has several functions, including:\n1. Inhibition of interferon signaling: The KP4 protein can inhibit the production of interferon, a protein that plays a crucial role in the immune response to viral infections. By inhibiting interferon signaling, the KP4 protein can prevent the host immune system from mounting a response to the virus.\n2. Activation of cellular signaling pathways: The KP4 protein can activate various cellular signaling pathways, including the PI3K/Akt and MAPK pathways, which can promote cell survival and proliferation.\n3. Regulation of gene expression: The KP4 protein can regulate the expression of viral genes, including the gene encoding the viral protein P30, which is involved in the replication of the virus.\n4. Inhibition of apoptosis: The KP4 protein can inhibit the induction of apoptosis, or programmed cell death, in infected cells. This can allow the virus to persist in the host for longer periods of time.\nOverall, the KP4 protein plays a critical role in the replication and pathogenesis of poxviruses, and its functions are essential for the virus to establish a productive infection in the host."
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "llama-2-7b-chat-hf_response": "Yes, DITPA (N-[4-(2-chloroethyl)-N-ethyl-2,3-bis(trifluoromethyl)pyridinium chloride) is a synthetic thyroid hormone analog that has been utilized in both experimental and clinical studies. It is a potent inhibitor of thyroid hormone synthesis and action, and has been used to investigate the role of thyroid hormones in various physiological processes, including metabolism, growth, and development. DITPA has also been used as a therapeutic agent in the treatment of certain thyroid disorders, such as thyroid cancer and Graves' disease."
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "llama-2-7b-chat-hf_response": "COUGER (Comprehensive Update of Genetic Information) is a tool used in bioinformatics and computational biology to predict the functional impact of non-synonymous single nucleotide variants (nsSNVs) in the human genome. It uses a machine learning approach to analyze the structural and evolutionary context of the variant, as well as the protein structure and function, to predict the possible effects of the variant on protein function and disease risk. COUGER is a comprehensive tool that integrates multiple types of data, including protein structure, protein-protein interactions, and gene expression data, to provide a more accurate prediction of the functional impact of nsSNVs."
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "llama-2-7b-chat-hf_response": "Yes, there are drugs available for the treatment of tick-borne encephalitis (TBE). The most commonly used drugs are:\n1. Antiviral medications: Oseltamivir (Tamiflu), Zanamivir (Relenza), and Peramivir (Rapivab) are the most commonly used antiviral medications for treating TBE. These medications can help reduce the severity and duration of symptoms, and may also help prevent complications.\n2. Corticosteroids: Corticosteroids, such as prednisone, may be prescribed to reduce inflammation in the brain and other parts of the body. They can help reduce symptoms such as headache, fever, and muscle weakness.\n3. Immunoglobulins: Immunoglobulins, such as intravenous immunoglobulin (IVIG), may be given to help boost the body's immune system and reduce the severity of TBE.\n4. Supportive care: Supportive care, such as rest, hydration, and pain management, is important for managing symptoms and preventing complications.\nIt's important to note that the best treatment approach for TBE may vary depending on the severity and location of the infection, as well as the individual patient's medical history and overall health. In some cases, a combination of these treatments may be used. It's important to consult a healthcare professional for proper diagnosis and treatment."
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "llama-2-7b-chat-hf_response": "There are several genome browsers and databases available for DNA shape annotations, including:\n1. ChromHMM: ChromHMM is a genome-scale model of chromatin structure and epigenetic marks, which provides DNA shape annotations for various organisms.\n2. HiC-Pro: HiC-Pro is a database of chromosome conformation capture (Hi-C) data, which provides information on the three-dimensional structure of chromosomes and the interactions between different regions.\n3. 4D-Nucleosome: 4D-Nucleosome is a database of nucleosome positioning and dynamics in different cell types and states, which provides information on the three-dimensional organization of nucleosomes and their interactions with other chromatin structures.\n4. ENCODE: The Encyclopedia of DNA Elements (ENCODE) project is a comprehensive database of chromatin modification profiles and functional genomics data, which provides information on the epigenetic marks and their functional implications.\n5. Roadmap Epigenomics: Roadmap Epigenomics is a database of epigenetic profiles and genomic annotations for various organisms, which provides information on the spatial and temporal patterns of epigenetic marks and their functional implications.\n6. Chromatin Atlas: Chromatin Atlas is a database of chromatin structure and epigenetic marks in various organisms, which provides information on the three-dimensional organization of chromatin and its interactions with other chromatin structures.\n7. H3K27ac ChIP-seq Peaks: H3K27ac ChIP-seq Peaks is a database of histone H3 lysine 27 acetylation (H3K27ac) ChIP-seq peaks in various organisms, which provides information on the genomic locations of H3K27ac peaks and their functional implications.\n8. H3K4me3 ChIP-seq Peaks: H3K4me3 ChIP-seq Peaks is a database of histone H3 lysine 4 methylation (H3K4me3) ChIP-seq peaks in various organisms, which provides information on the genomic locations of H3K4me3 peaks and their functional implications.\n9. H3K27me3 ChIP-seq Peaks:"
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "llama-2-7b-chat-hf_response": "The EZH2 gene has been associated with several syndromes, including:\n1. Beckwith-Wiedemann syndrome (BWS): This is a genetic disorder that affects the development of various organs and tissues, including the brain, kidneys, and pancreas.\n2. Silver-Russell syndrome (SRS): This is a rare genetic disorder that affects growth and development, and is characterized by short stature, delayed speech and cognitive development, and distinctive facial features.\n3. Lyon syndrome: This is a rare genetic disorder that affects the development of various organs and tissues, including the brain, kidneys, and pancreas.\n4. Hutchinson-Gilford progeria syndrome (HGPS): This is a rare genetic disorder that causes accelerated aging in children, resulting in a shortened lifespan.\n5. Langer syndrome: This is a rare genetic disorder that affects the development of various organs and tissues, including the brain, kidneys, and pancreas.\nThese syndromes are caused by mutations in the EZH2 gene, which can lead to abnormalities in the regulation of gene expression and the development of various tissues and organs."
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "llama-2-7b-chat-hf_response": "There are several human proteins that are known to undergo a dimer-to-tetramer transition, including:\n1. p53: The tumor suppressor protein p53 undergoes a dimer-to-tetramer transition in response to DNA damage, leading to the activation of its transcriptional activity.\n2. Myc: The Myc transcription factor also undergoes a dimer-to-tetramer transition, which is important for its ability to regulate gene expression.\n3. E2F1: The E2F transcription factor E2F1 undergoes a dimer-to-tetramer transition in response to growth factors and nutrient availability, leading to the activation of cell cycle progression.\n4. c-Jun: The transcription factor c-Jun undergoes a dimer-to-tetramer transition in response to growth factors and stress, leading to the activation of gene expression.\n5. c-Myc: The transcription factor c-Myc undergoes a dimer-to-tetramer transition in response to growth factors and nutrient availability, leading to the activation of gene expression.\n6. Max: The transcription factor Max undergoes a dimer-to-tetramer transition in response to growth factors and nutrient availability, leading to the activation of gene expression.\n7. Myb: The transcription factor Myb undergoes a dimer-to-tetramer transition in response to growth factors and nutrient availability, leading to the activation of gene expression.\n8. GATA-1: The transcription factor GATA-1 undergoes a dimer-to-tetramer transition in response to growth factors and nutrient availability, leading to the activation of gene expression.\n9. NF-κB: The transcription factor NF-κB undergoes a dimer-to-tetramer transition in response to growth factors and inflammatory signals, leading to the activation of gene expression.\n10. STAT3: The transcription factor STAT3 undergoes a dimer-to-tetramer transition in response to growth factors and inflammatory signals, leading to the activation of gene expression.\nIt's worth not"
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "llama-2-7b-chat-hf_response": "One protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is BCL-2 (B-cell lymphoma 2)."
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "llama-2-7b-chat-hf_response": "Yes, several clinical trials have shown that vitamin D supplementation can reduce the incidence of falls in older people. Here are some examples:\n1. A 2013 Cochrane review of 15 randomized controlled trials found that vitamin D supplementation was associated with a significant reduction in the risk of falls in older adults (1).\n2. A 2014 meta-analysis of 11 randomized controlled trials found that vitamin D supplementation reduced the risk of falls by 23% in older adults (2).\n3. A 2017 randomized controlled trial found that vitamin D supplementation reduced the incidence of falls in older adults with a history of falls (3).\n4. A 2019 systematic review and meta-analysis of 23 randomized controlled trials found that vitamin D supplementation was associated with a reduced risk of falls in older adults, with a pooled relative risk reduction of 23% (4).\nOverall, the evidence suggests that vitamin D supplementation may be effective in reducing the incidence of falls in older people, although the exact mechanisms by which this occurs are not fully understood. However, it is thought that vitamin D may play a role in maintaining muscle strength and function, as well as in the regulation of neuromuscular transmission and balance."
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "llama-2-7b-chat-hf_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells. Jarid2 (Jumonji-ATF-interacting protein 2) is a histone-modifying enzyme that regulates chromatin structure and gene expression, and miR-155 (microRNA-155) is a small non-coding RNA that plays a critical role in the regulation of Th17 cell differentiation and inflammation. Studies have shown that Jarid2 and miR-155 interact in Th17 cells, with Jarid2 promoting the expression of miR-155 and miR-155 in turn regulating the expression of genes involved in Th17 cell differentiation and function."
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "llama-2-7b-chat-hf_response": "The human HoxD cluster contains 9 genes: Hoxd-1 to Hoxd-9."
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "llama-2-7b-chat-hf_response": "Casein Kinase 1 (CK1) is a serine/threonine kinase that phosphorylates a variety of substrates in cells. The consensus motifs for phosphorylation by CK1 are:\n1. Ser/Thr-Pro-X-X-Ser/Thr (where X is any amino acid)\nThis motif is found in the activation loops of many CK1 substrates and is important for their phosphorylation and activity.\n2. Ser/Thr-X-X-Ser/Thr (where X is any amino acid)\nThis motif is found in the regulatory regions of CK1 substrates and is important for their phosphorylation and inhibition by CK1.\n3. Ser/Thr-Gly-X-X-Ser/Thr (where X is any amino acid)\nThis motif is found in the substrate sequences of CK1 and is important for their phosphorylation and activity.\n4. Ser/Thr-Pro-X-X-Ser/Thr-Pro (where X is any amino acid)\nThis motif is found in the substrate sequences of CK1 and is important for their phosphorylation and activity.\n5. Ser/Thr-X-X-Ser/Thr-X (where X is any amino acid)\nThis motif is found in the substrate sequences of CK1 and is important for their phosphorylation and activity.\nIt's worth noting that these consensus motifs are not exclusive to CK1 and other kinases can also phosphorylate these sites, but these are the most common consensus motifs found in CK1 substrates."
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "llama-2-7b-chat-hf_response": "The ASPH (aspartate beta-hydroxylase) gene in humans encodes multiple isoforms of the ASPH protein, including:\n1. ASPH1: The full-length form of the ASPH protein, which is the most well-studied isoform.\n2. ASPH2: A shorter isoform that lacks the N-terminal region of the protein.\n3. ASPH3: A splice variant that is produced through alternative splicing and contains a distinct C-terminal region.\n4. ASPH4: A variant that is produced through a mutation in the ASPH gene and has been associated with certain diseases, including cancer.\n5. ASPH5: A form of the protein that is produced through a post-translational modification, such as phosphorylation.\nThese isoforms of ASPH have different functions and are involved in various cellular processes, including cell signaling, cytoskeleton organization, and regulation of gene expression."
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "llama-2-7b-chat-hf_response": "Empagliflozin was FDA approved in 2014. It was approved on June 28, 2014, by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes."
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "llama-2-7b-chat-hf_response": "Loss of the protein Lon1 in the plant Arabidopsis thaliana has been shown to have several effects on plant development and physiology. Some of the key results include:\n1. Delayed growth and reduced stem elongation: Lon1-deficient plants are smaller and have delayed growth compared to wild-type plants.\n2. Altered leaf morphology: Lon1-deficient leaves are thicker and have a smaller blade size compared to wild-type leaves.\n3. Reduced flowering: Lon1-deficient plants produce fewer flowers and have a reduced fertility compared to wild-type plants.\n4. Increased sensitivity to abiotic stress: Lon1-deficient plants are more sensitive to abiotic stressors such as drought and high temperature.\n5. Altered root architecture: Lon1-deficient roots are shorter and have a reduced number of lateral roots compared to wild-type roots.\n6. Reduced tolerance to oxidative stress: Lon1-deficient plants have reduced tolerance to oxidative stress, as evidenced by increased sensitivity to the oxidative stress-inducing agent, H2O2.\n7. Altered hormone regulation: Lon1-deficient plants have altered levels of various hormones, including ABA, ethylene, and cytokinin, which can affect plant growth and development.\n8. Changes in gene expression: Lon1-deficient plants have altered expression of various genes involved in various cellular processes, including DNA repair, stress response, and cell division.\nThese results demonstrate that Lon1 plays a critical role in regulating various aspects of plant growth and development, and that its loss can have significant effects on plant physiology and stress tolerance."
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "llama-2-7b-chat-hf_response": "Yes, a linker histone called H3K56ac exists in the yeast genome. H3K56ac is a histone modification that plays a role in the regulation of chromatin structure and gene expression, particularly in the context of transcriptional elongation. In yeast, H3K56ac is known to be involved in the regulation of various cellular processes, including cell cycle progression, DNA repair, and stress response."
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "llama-2-7b-chat-hf_response": "Yes, there is some evidence to suggest that tomato juice may help lower cholesterol levels.\nTomato juice contains a compound called lycopene, which has been shown to have cholesterol-lowering effects. Lycopene is a powerful antioxidant that can help reduce inflammation and improve cardiovascular health.\nSeveral studies have investigated the potential of tomato juice to lower cholesterol levels. A 2011 study published in the Journal of Nutrition found that drinking tomato juice for 12 weeks significantly reduced total cholesterol and LDL (bad) cholesterol levels in healthy adults. Another study published in the Journal of Agricultural and Food Chemistry in 2015 found that lycopene from tomato juice reduced cholesterol levels in mice fed a high-cholesterol diet.\nIt's thought that the lycopene in tomato juice may help lower cholesterol levels by reducing the absorption of dietary cholesterol in the gut, as well as by inhibiting the production of cholesterol in the liver. Additionally, lycopene may help improve the function of the LDL (bad) cholesterol receptor, which can help remove excess cholesterol from the bloodstream.\nWhile these findings are promising, it's important to note that the evidence for the cholesterol-lowering effects of tomato juice is still emerging and more research is needed to fully understand its potential benefits. Additionally, it's important to remember that tomato juice is just one part of a healthy diet and lifestyle, and it's not a substitute for other cholesterol-lowering strategies, such as a balanced diet, regular exercise, and medication if necessary."
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "llama-2-7b-chat-hf_response": "Hsp70 and Hsp110 are molecular chaperones that play a role in regulating mRNA stability by interacting with the 3' untranslated region (UTR) of target mRNAs and modulating their stability.\nHsp70:\n* Hsp70 binds to the 3' UTR of target mRNAs and protects them from degradation by the 5' to 3' exonuclease activity of the ribosome.\n* Hsp70 can also induce a conformational change in the 3' UTR that inhibits the activity of the ribosome, leading to increased mRNA stability.\n* Hsp70 can also regulate mRNA stability by modulating the activity of other proteins involved in mRNA degradation, such as the E3 ubiquitin ligase complex.\nHsp110:\n* Hsp110 also binds to the 3' UTR of target mRNAs and protects them from degradation by the ribosome.\n* Hsp110 can induce a conformational change in the 3' UTR that inhibits the activity of the ribosome, leading to increased mRNA stability.\n* Hsp110 can also regulate mRNA stability by modulating the activity of other proteins involved in mRNA degradation, such as the E3 ubiquitin ligase complex.\nIn summary, both Hsp70 and Hsp110 regulate mRNA stability by interacting with the 3' UTR of target mRNAs and modulating the activity of the ribosome and other proteins involved in mRNA degradation."
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "llama-2-7b-chat-hf_response": "There are two deiodinases present in skeletal muscle:\n1. Deiodinase type 1 (D1): found primarily in the brain and other organs, but also expressed in skeletal muscle, where it plays a role in regulating muscle mass and function.\n2. Deiodinase type 2 (D2): primarily expressed in skeletal muscle, where it is responsible for the conversion of T4 to T3, the active form of the hormone, which plays a crucial role in regulating muscle metabolism and growth."
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "llama-2-7b-chat-hf_response": "Caspase proteins are a family of enzymes that play a central role in the inflammatory response. Here are some of the inflammatory caspase proteins:\n1. Caspase-1 (also known as interleukin-1β converting enzyme, or ICE): This caspase is involved in the processing and activation of pro-inflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α).\n2. Caspase-3: This caspase is involved in the cleavage of a variety of inflammatory proteins, including the pro-inflammatory cytokines IL-1β and TNF-α, as well as the anti-inflammatory cytokine interleukin-10 (IL-10).\n3. Caspase-6: This caspase is involved in the processing and activation of pro-inflammatory cytokines such as IL-1β and TNF-α.\n4. Caspase-7: This caspase is involved in the cleavage of a variety of inflammatory proteins, including the pro-inflammatory cytokines IL-1β and TNF-α, as well as the anti-inflammatory cytokine IL-10.\n5. Caspase-8: This caspase is involved in the processing and activation of pro-inflammatory cytokines such as Fas ligand (FasL) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).\n6. Caspase-9: This caspase is involved in the cleavage of a variety of inflammatory proteins, including the pro-inflammatory cytokines IL-1β and TNF-α, as well as the anti-inflammatory cytokine IL-10.\n7. Caspase-12: This caspase is involved in the processing and activation of pro-inflammatory cytokines such as IL-1β and TNF-α.\n8. Caspase-13: This caspase is involved in the cleavage of a"
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "llama-2-7b-chat-hf_response": "Yes, there is a link between Aurora B kinase and the polycomb protein Ring1B. Ring1B is a member of the polycomb repressive complex 2 (PRC2) and is involved in the regulation of gene expression, particularly during cell division. Aurora B kinase, on the other hand, is a serine/threonine kinase that plays a critical role in the proper separation of chromosomes during mitosis and meiosis.\nStudies have shown that Ring1B and Aurora B kinase interact and coordinate their functions during mitosis. Ring1B is phosphorylated by Aurora B kinase, which leads to its activation and the subsequent regulation of chromatin remodeling and gene expression. In addition, Ring1B has been shown to regulate the localization and activity of Aurora B kinase, providing a negative feedback loop that helps to ensure proper chromosome segregation.\nIn summary, there is a functional link between Aurora B kinase and the polycomb protein Ring1B, with each protein playing a critical role in the regulation of chromatin dynamics and gene expression during cell division."
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "llama-2-7b-chat-hf_response": "Non-canonical sequence motifs are alterations in the splice site sequences that can disrupt the normal splicing process. In vertebrates, the most frequent non-canonical sequence motifs at the donor and acceptor splice sites are:\nDonor splice sites:\n* GU-rich sequences (GU4-7)\n* GU-rich clusters (2-4 GU bases in a row)\n* GA-rich sequences (GA4-7)\n* GA-rich clusters (2-4 GA bases in a row)\n* AG-rich sequences (AG4-7)\n* AG-rich clusters (2-4 AG bases in a row)\n* A-rich sequences (A4-7)\n* A-rich clusters (2-4 A bases in a row)\n* T-rich sequences (T4-7)\n* T-rich clusters (2-4 T bases in a row)\n* GT-rich sequences (GT4-7)\n* GT-rich clusters (2-4 GT bases in a row)\nAcceptor splice sites:\n* GU-rich sequences (GU4-7)\n* GU-rich clusters (2-4 GU bases in a row)\n* GA-rich sequences (GA4-7)\n* GA-rich clusters (2-4 GA bases in a row)\n* AG-rich sequences (AG4-7)\n* AG-rich clusters (2-4 AG bases in a row)\n* A-rich sequences (A4-7)\n* A-rich clusters (2-4 A bases in a row)\n* T-rich sequences (T4-7)\n* T-rich clusters (2-4 T bases in a row)\n* GT-rich sequences (GT4-7)\n* GT-rich clusters (2-4 GT bases in a row)\nIt's worth noting that the frequency of these non-canonical motifs can vary depending on the tissue and cell type, and some of these motifs may also be found in other organisms."
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "llama-2-7b-chat-hf_response": "S6K1 (S6 kinase 1) is acetylated in response to activation of the PI3K (phosphoinositide 3-kinase) signaling pathway. Specifically, the phosphatidylinositol 3,4,5-trisphosphate (PIP3) produced downstream of PI3K activation binds to and recruits S6K1 to the plasma membrane, where it is acetylated by the histone acetyltransferase (HAT) complex p300/CBP-associated factor (PCAF)."
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "llama-2-7b-chat-hf_response": "Episodic ataxia type 6 (EA6) is a rare genetic disorder that is caused by mutations in the CACNA1A gene. This gene encodes a subunit of a calcium channel that is important for the transmission of calcium signals in neurons. Mutations in the CACNA1A gene lead to a loss of function of the calcium channel, resulting in the episodic ataxia symptoms."
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "llama-2-7b-chat-hf_response": "Yes, chromomethylases are present in animal genomes. Chromomethylases are enzymes that modify chromatin structure by adding methyl groups to specific histone residues, and they play important roles in regulating chromatin dynamics and gene expression in both prokaryotes and eukaryotes.\nIn animals, chromomethylases have been identified as playing a role in a variety of processes, including:\n1. Epigenetic regulation of gene expression: Chromomethylases can modify histone H3 and H4 residues, leading to changes in chromatin structure and accessibility to transcription factors, and thereby affecting gene expression.\n2. Chromosome stability: Chromomethylases can help maintain chromosome stability by preventing the formation of chromatin structures that could lead to chromosomal abnormalities.\n3. Cell fate determination: Chromomethylases have been implicated in the regulation of cell fate determination, particularly in the context of stem cell differentiation.\n4. Cancer: Chromomethylases have been implicated in cancer development and progression, as alterations in their expression or activity can lead to changes in chromatin structure and gene expression that contribute to tumorigenesis.\nOverall, chromomethylases are an important class of enzymes that play a complex and multifaceted role in animal cell biology, and their dysregulation can have significant consequences for cellular function and health."
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "llama-2-7b-chat-hf_response": "There are several packages available in R/Bioconductor for the analysis of transcription factor binding sites (TFBS):\n1. ChromHMM: This package uses a hidden Markov model (HMM) to predict TFBS in DNA sequences. It can also be used to predict other types of genomic features such as gene regulatory elements.\n2. TFBSpred: This package uses a combination of machine learning algorithms and sequence motif discovery methods to predict TFBS in DNA sequences. It can also be used to predict the binding affinity of transcription factors to their target sites.\n3. TRANSFAC: This package is a comprehensive database of transcription factor binding sites and their corresponding binding sites. It can be used to predict TFBS in new DNA sequences or to identify potential binding sites in a given sequence.\n4. RSAT: This package uses a statistical approach to predict TFBS in DNA sequences. It can also be used to predict the binding affinity of transcription factors to their target sites.\n5. GREAT: This package uses a combination of machine learning algorithms and sequence motif discovery methods to predict TFBS in DNA sequences. It can also be used to predict the binding affinity of transcription factors to their target sites.\n6. DeepSEA: This package uses deep learning methods to predict TFBS in DNA sequences. It can also be used to predict the binding affinity of transcription factors to their target sites.\n7. TFBS-predict: This package uses a combination of sequence motif discovery methods and machine learning algorithms to predict TFBS in DNA sequences.\n8. TF-Predict: This package uses a combination of sequence motif discovery methods and machine learning algorithms to predict TFBS in DNA sequences.\n9. Chromatin-Motif-Predictor: This package uses a combination of sequence motif discovery methods and machine learning algorithms to predict TFBS in DNA sequences.\n10. Transcription-Factor-Predictor: This package uses a combination of sequence motif discovery methods and machine learning algorithms to predict TFBS in DNA sequences.\nIt's worth noting that these packages are constantly being updated and new packages are being developed, so it's a good idea to check the latest packages available in R/Bioconductor and the documentation for each package to see which one is"
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "llama-2-7b-chat-hf_response": "Here are some clinical trials related to the prevention of sarcopenia:\n1. \"Exercise and Nutrition Interventions to Prevent Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis\" (2019) - This study published in the Journal of the American Medical Directors Association found that exercise and nutrition interventions can help prevent sarcopenia in older adults.\n2. \"Effects of Resistance Training on Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis\" (2018) - This study published in the Journal of Aging and Physical Activity found that resistance training can help prevent sarcopenia in older adults.\n3. \"The Effects of Omega-3 Fatty Acids on Sarcopenia in Older Adults: A Systematic Review\" (2018) - This study published in the Journal of the American Geriatrics Society found that omega-3 fatty acid supplementation may help prevent sarcopenia in older adults.\n4. \"Effects of Vitamin D and Omega-3 Fatty Acid Supplementation on Sarcopenia in Older Adults: A Randomized Controlled Trial\" (2017) - This study published in the Journal of the American Geriatrics Society found that vitamin D and omega-3 fatty acid supplementation may help prevent sarcopenia in older adults.\n5. \"Resistance Training and Nutrition Interventions to Prevent Sarcopenia in Older Adults: A Randomized Controlled Trial\" (2017) - This study published in the Journal of the American Geriatrics Society found that a combination of resistance training and nutrition interventions can help prevent sarcopenia in older adults.\n6. \"The Effects of Tai Chi Exercise on Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis\" (2017) - This study published in the Journal of Aging and Physical Activity found that tai chi exercise can help prevent sarcopenia in older adults.\n7. \"Effects of Probiotic Supplementation on Sarcopenia in"
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "llama-2-7b-chat-hf_response": "There are several databases of molecular recognition features in membrane proteins, but some of the most well-known and widely used include:\n1. The Membrane Protein Database (MPD): This database contains a collection of structurally and functionally annotated membrane proteins, including their sequences, structures, and functional information.\n2. The Protein Data Bank (PDB): This database contains a large collection of 3D structures of proteins, including membrane proteins, and their complexes with ligands and other molecules.\n3. The Membrane Protein Structural Alignment (MPSA): This database provides a collection of aligned structures of membrane proteins, allowing for the comparison of their structural features and the identification of conserved regions.\n4. The Membrane Protein Interaction Database (MPI): This database contains information on the interactions between membrane proteins and other molecules, including ligands, other proteins, and small molecules.\n5. The Membrane Protein Functional Site Database (MPFSD): This database provides information on the functional sites of membrane proteins, including their binding sites, active sites, and other functional regions.\n6. The Membrane Protein-Ligand Interaction Database (MPLID): This database contains information on the interactions between membrane proteins and their ligands, including the binding affinity and specificity of these interactions.\n7. The Membrane Protein-Protein Interaction Database (MPPI): This database provides information on the interactions between membrane proteins and other proteins, including their binding affinity and specificity.\n8. The Membrane Protein-Nucleic Acid Interaction Database (MPNA): This database contains information on the interactions between membrane proteins and nucleic acids, including their binding affinity and specificity.\n9. The Membrane Protein-Small Molecule Interaction Database (MPSMI): This database provides information on the interactions between membrane proteins and small molecules, including their binding affinity and specificity.\n10. The Membrane Protein-Drug Interaction Database (MPDI): This database contains information on the interactions between membrane proteins and drugs, including their binding affinity and specificity.\nThese databases are valuable resources for understanding the structure and function of memb"
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "llama-2-7b-chat-hf_response": "Yes, rivaroxaban is metabolized in the kidneys. Rivaroxaban is primarily metabolized by the liver and kidneys, with the liver being the primary site of metabolism. The kidneys play a secondary role in metabolizing rivaroxaban, converting it into inactive metabolites that are then eliminated from the body."
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "llama-2-7b-chat-hf_response": "TRα2 regulates the expression of several genes in the heart, including:\n1. ANF (α-myosin heavy chain): TRα2 binds to the ANF promoter and enhances its activity, leading to increased cardiac myosin heavy chain expression and contractility.\n2. BNP (brain natriuretic peptide): TRα2 inhibits the expression of BNP, a hormone involved in cardiac remodeling and failure.\n3. CAV1 (caveolin-1): TRα2 regulates the expression of CAV1, a protein involved in cardiac ion channels and contraction.\n4. GATA4 (GATA-binding protein 4): TRα2 regulates the expression of GATA4, a transcription factor involved in cardiac development and differentiation.\n5. Mef2c (myocyte-specific enhancer factor 2C): TRα2 regulates the expression of Mef2c, a transcription factor involved in cardiac hypertrophy and adaptation.\n6. NFATc3 (nuclear factor of activated T cells 3): TRα2 regulates the expression of NFATc3, a transcription factor involved in T cell activation and cardiac hypertrophy.\n7. TNNI3 (troponin I3): TRα2 regulates the expression of TNNI3, a protein involved in cardiac contractility and relaxation.\n8. TNNT2 (troponin T2): TRα2 regulates the expression of TNNT2, a protein involved in cardiac contractility and relaxation.\nThese genes are regulated by TRα2 in the heart, and their dysregulation can lead to various cardiac diseases, including hypertension, heart failure, and arrhythmias."
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "llama-2-7b-chat-hf_response": "There are several biomedical question answering systems available, including:\n1. PubMed Central's \"Ask a Biologist\": This system allows users to ask questions related to biology and medicine and receive answers from a community of scientists and experts.\n2. IBM's Watson for Oncology: This system uses natural language processing and machine learning to answer questions related to cancer diagnosis and treatment.\n3. The Biomedical Informatics Research Laboratory's \"BioQA\": This system is a comprehensive biomedical question answering system that can answer questions on a wide range of topics, including genetics, proteomics, and drug discovery.\n4. The National Center for Biotechnology Information's (NCBI) \"Bookshelf\": This system provides access to a collection of biomedical books and other resources, including a question answering feature that allows users to ask and answer questions on various biomedical topics.\n5. The Biomedical Information and Technology Initiative's (BITI) \"BioQA\": This system is a web-based question answering system that can answer questions on a wide range of biomedical topics, including genetics, proteomics, and drug discovery.\n6. The University of California, San Diego's \"BioQuestions\": This system is a web-based question answering system that can answer questions on a wide range of biomedical topics, including genetics, proteomics, and drug discovery.\n7. The University of Texas Southwestern Medical Center's \"UTSW BioQA\": This system is a web-based question answering system that can answer questions on a wide range of biomedical topics, including genetics, proteomics, and drug discovery.\n8. The University of Pennsylvania's \"Penn BioQA\": This system is a web-based question answering system that can answer questions on a wide range of biomedical topics, including genetics, proteomics, and drug discovery.\n9. The University of California, Los Angeles's \"UCLA BioQA\": This system is a web-based question answering system that can answer questions on a wide range of biomedical topics, including genetics, proteomics, and drug discovery.\n10. The University of California, San Francisco's \"UCSF BioQA\": This system is a web"
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "llama-2-7b-chat-hf_response": "The transcription factor that activates the bethanechol pathway is ABSCISIC ACID INSENSITIVE 3 (ABI3)."
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "llama-2-7b-chat-hf_response": "There are several technologies that are commonly used for enriching phosphorylated peptides in global quantitative phosphoproteomic analyses. Here are some of the preferred technologies:\n1. TiO2-based enrichment: This method uses titanium dioxide (TiO2) to selectively capture phosphorylated peptides based on their negative charge. The sample is incubated with TiO2 beads, which bind to the phosphate groups on the peptides, resulting in their enrichment.\n2. IMAC (immunomagnetic bead) purification: This method uses magnetic beads coated with anti-phosphotyrosine antibodies to isolate phosphorylated peptides. The sample is incubated with the beads, which bind to the phosphorylated peptides, and then the beads are magnetically separated from the rest of the sample.\n3. RESOURCE (rapid enrichment of phosphorylated peptides using immobilized reagents): This method uses a combination of TiO2 beads and a specific reagent, such as a phosphotyrosine antibody, to enrich for phosphorylated peptides. The sample is incubated with the beads and reagent, which bind to the phosphorylated peptides, resulting in their enrichment.\n4. Blue-native PAGE (BN-PAGE): This method uses a specialized gel system that separates proteins based on their size and phosphorylation state. The sample is separated on a gel, and then the phosphorylated proteins are visualized and isolated using a specific reagent.\n5. Pro-Q Diamond: This method uses a fluorescent dye that selectively binds to phosphorylated peptides, allowing for their visualization and isolation. The sample is incubated with the dye, and then the phosphorylated peptides are isolated using a specific reagent.\n6. MALDI-TOF (matrix-assisted laser desorption/ionization time-of-flight) mass spectrometry: This method uses a combination of a matrix and a laser to ionize and detect phosph"
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "llama-2-7b-chat-hf_response": "Palmini classification is used to rate the severity of intellectual disability. It categorizes intellectual disability into different levels of severity, ranging from mild to severe."
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "llama-2-7b-chat-hf_response": "Yes, some viruses have been implicated in the etiology of human subacute thyroiditis. Subacute thyroiditis is an inflammatory condition that affects the thyroid gland and can cause thyroid hormone imbalances. While the exact cause of subacute thyroiditis is not fully understood, some viral infections have been linked to the development of the condition.\nSome viruses that have been associated with subacute thyroiditis include:\n1. Viruses of the enterovirus genus: Enteroviruses are common viruses that can cause a range of illnesses, including subacute thyroiditis. Studies have shown that enteroviruses can infect the thyroid gland and trigger an immune response that leads to inflammation and thyroid dysfunction.\n2. Herpesviruses: Herpesviruses, such as herpes simplex virus (HSV) and human herpesvirus 6 (HHV-6), have also been linked to subacute thyroiditis. HSV has been shown to infect the thyroid gland and cause inflammation, while HHV-6 has been associated with thyroiditis in some studies.\n3. Adenoviruses: Adenoviruses are another type of virus that has been implicated in the development of subacute thyroiditis. Adenovirus infection of the thyroid gland can lead to inflammation and thyroid dysfunction.\n4. Respiratory syncytial virus (RSV): RSV is a common virus that affects the respiratory system and can cause lower respiratory tract infections. Some studies have suggested that RSV may also play a role in the development of subacute thyroiditis.\nIt's important to note that not everyone who develops subacute thyroiditis will have a viral infection, and the condition can also be caused by other factors, such as autoimmune disorders or exposure to certain medications. However, viral infections are a common trigger for subacute thyroiditis, and identifying the underlying cause of the condition can help guide treatment and management."
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "llama-2-7b-chat-hf_response": "Yes, STAT3 (Signal Transducer and Activator of Transcription 3) is involved in EIF2AK2-dependent suppression of autophagy. EIF2AK2 (Eukaryotic Initiation Factor 2-Associated Kinase 2) is a kinase that phosphorylates and inhibits the translation initiation factor eIF2α, leading to suppression of global protein synthesis and induction of autophagy. STAT3 is a transcription factor that regulates the expression of genes involved in various cellular processes, including autophagy. Studies have shown that STAT3 is activated downstream of EIF2AK2 and plays a role in the regulation of autophagy under conditions of cellular stress, such as during cancer development and progression."
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "llama-2-7b-chat-hf_response": "Theatre is a software tool used for genomic analysis, particularly for the analysis of genomic variation data. It is designed to be used in conjunction with the BAM (Binary Alignment/Map) format, which is a common format for storing genomic sequencing data.\nTheatre can be used for a variety of genomic analysis tasks, including:\n1. Genome assembly: Theatre can be used to assemble genomes from DNA sequencing data, by aligning the sequencing reads to a reference genome and reconstructing the original DNA sequence.\n2. Variant calling: Theatre can be used to identify genetic variants (such as single nucleotide polymorphisms, insertions, deletions, and copy number variations) in a genome by aligning the sequencing reads to the reference genome and identifying differences between the two.\n3. Genome mapping: Theatre can be used to map sequencing reads to a reference genome, allowing researchers to identify which regions of the genome are covered by the sequencing data.\n4. Transcriptome analysis: Theatre can be used to analyze the transcriptome (the set of RNA molecules present in a cell or organism) by aligning RNA-seq reads to a reference genome or transcriptome.\n5. Epigenomics analysis: Theatre can be used to analyze epigenetic marks (such as DNA methylation and histone modifications) by aligning sequencing reads to a reference genome and identifying differences in the epigenetic marks between different regions of the genome.\n6. Methylation analysis: Theatre can be used to analyze DNA methylation patterns in a genome by aligning sequencing reads to a reference genome and identifying differences in methylation levels between different regions of the genome.\n7. ChIP-seq analysis: Theatre can be used to analyze ChIP-seq data (which is used to identify protein-DNA interactions) by aligning sequencing reads to a reference genome and identifying regions of the genome where a particular protein is bound.\n8. Genome-wide association studies (GWAS): Theatre can be used to identify genetic variants associated with a particular disease or trait by analyzing genome-wide variation data.\nOverall, Theatre is a powerful tool for genomic analysis, allowing researchers to align sequencing reads to a reference genome"
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "llama-2-7b-chat-hf_response": "The execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences depends on the length of the sequences and the type of comparison being made.\nFor the basic Smith-Waterman algorithm, the time complexity is O(n^2), where n is the length of the shorter sequence. This is because the algorithm needs to compare each element of the shorter sequence with every element of the longer sequence, resulting in a total of n^2 comparisons.\nHowever, there are several variations of the Smith-Waterman algorithm that have different time complexities:\n* The Needleman-Wunsch algorithm, which is a variation of the Smith-Waterman algorithm that uses a different scoring function, has a time complexity of O(n log n).\n* The global Smith-Waterman algorithm, which is a variation of the Smith-Waterman algorithm that uses a global alignment strategy, has a time complexity of O(n^3).\n* The parallel Smith-Waterman algorithm, which is a variation of the Smith-Waterman algorithm that uses parallel processing to speed up the computation, has a time complexity of O(n^2 parallel operations).\nIt's worth noting that these time complexities are approximate and can vary depending on the specific implementation and the input sequences."
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "llama-2-7b-chat-hf_response": "FLVCR1 is a member of the solute carrier (SLC) family of transmembrane transporters. Specifically, it is a member of the SLC12A family, which is also known as the hydroxyl-carboxylate carrier family."
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "llama-2-7b-chat-hf_response": "GATA-1 is a transcription factor that plays a crucial role in regulating gene expression in hematopoietic cells. The biotinylation tagging approach has been used to identify GATA-1 interacting partners. Some of the known interacting partners of GATA-1 include:\n1. BCL-6: GATA-1 and BCL-6 are transcription factors that are important for the regulation of immune cell differentiation and function. They interact directly and cooperatively regulate the expression of multiple genes involved in these processes.\n2. CBX3: CBX3 is a chromodomain-containing protein that is involved in the regulation of gene expression, particularly in the context of hematopoiesis. GATA-1 and CBX3 interact directly and cooperatively regulate the expression of genes involved in erythropoiesis.\n3. KAT2A: KAT2A is a histone acetyltransferase that is involved in the regulation of chromatin structure and gene expression. GATA-1 and KAT2A interact directly and cooperatively regulate the expression of genes involved in hematopoiesis.\n4. PPARγ: PPARγ is a nuclear receptor that is involved in the regulation of glucose metabolism and adipocyte differentiation. GATA-1 and PPARγ interact indirectly, with GATA-1 regulating the expression of genes involved in glucose metabolism and PPARγ regulating the expression of genes involved in adipocyte differentiation.\n5. TFAP2A: TFAP2A is a transcription factor that is involved in the regulation of gene expression in various cell types, including hematopoietic cells. GATA-1 and TFAP2A interact directly and cooperatively regulate the expression of genes involved in hematopoiesis.\n6. TFAP2C: TFAP2C is a transcription factor that is involved in the regulation of gene expression in various cell types, including hematopoietic cells. GATA-1 and TFAP2C interact directly and cooperatively regulate the expression of genes involved in hematopoiesis.\n7. TAL1: TAL1 is a trans"
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "llama-2-7b-chat-hf_response": "TAF10 (TATA-binding protein-associated factor 10) interacts with the GATA1 (GATA-binding protein 1) transcription factor to regulate the expression of genes involved in erythroid cell development. The interaction between TAF10 and GATA1 leads to the recruitment of RNA polymerase II to the promoter region of target genes, which are involved in the final stages of erythropoiesis, including the synthesis of hemoglobin and other erythrocyte-specific proteins. This outcome is crucial for the proper differentiation and maturation of red blood cells."
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "llama-2-7b-chat-hf_response": "Yes, there are several decision support systems (DSS) available for chronic pain management. These systems are designed to help healthcare providers make informed decisions about the management of chronic pain, taking into account the patient's individual needs and medical history. Some of the key features of these systems include:\n1. Clinical decision support systems (CDSSs): These systems use algorithms and clinical guidelines to provide healthcare providers with recommendations for pain management based on the patient's medical history and current symptoms.\n2. Patient-facing decision support systems (PDSs): These systems provide patients with information and tools to help them make informed decisions about their pain management, such as pain assessment tools, treatment options, and pain management strategies.\n3. Telemedicine and remote monitoring systems: These systems allow healthcare providers to remotely monitor patients with chronic pain and provide real-time feedback and support.\n4. Artificial intelligence (AI) and machine learning (ML) systems: These systems use machine learning algorithms to analyze large datasets and provide personalized recommendations for pain management based on the patient's individual characteristics and treatment history.\n5. Integrated pain management platforms: These platforms bring together various tools and resources for chronic pain management, such as CDSSs, PDSs, and telemedicine systems, into a single, integrated system.\nSome examples of decision support systems for chronic pain management include:\n1. The Chronic Pain Management Decision Support System (CPMDSS): This system provides healthcare providers with evidence-based recommendations for pain management based on the patient's medical history and current symptoms.\n2. The Pain Management Collaborative (PMC): This system provides healthcare providers with a framework for multidisciplinary pain management, including clinical guidelines, treatment protocols, and quality improvement initiatives.\n3. The American Pain Society's Pain Management Consultation Tool (PMC-T): This system provides healthcare providers with a structured framework for pain management consultations, including assessment tools, treatment recommendations, and follow-up strategies.\n4. The National Pain Management Collaboratory's (NPMC) Pain Management Decision Support System (PMDSS): This system provides healthcare providers with evidence-"
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "llama-2-7b-chat-hf_response": "Angiogenin is a protein that is localized primarily in the cytoplasm and nucleus of cells."
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "llama-2-7b-chat-hf_response": "Ranolazine is a drug that has been shown to inhibit the activation of kinase signaling pathways in the heart, particularly the Akt/PKB signaling pathway. Ranolazine works by blocking the activity of the enzyme ATP-dependent phosphate translocator (ANT), which is involved in the transport of phosphate groups from the cytosol to the membrane. This inhibition of ANT activity reduces the activation of Akt/PKB signaling pathway, which is involved in cell survival and metabolism. By inhibiting the activation of Akt/PKB signaling pathway, ranolazine can reduce the proliferation of cardiac cells and inhibit the development of heart failure."
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "llama-2-7b-chat-hf_response": "No, the regulation of Vsr endonuclease is not entirely independent of the growth phase of bacteria. While Vsr is induced in response to DNA damage and is active in both log and stationary phases of growth, the level of Vsr induction and activity can vary depending on the growth phase. For example, one study found that Vsr expression is higher in the stationary phase than in the log phase of growth, suggesting that the enzyme may play a role in the resolution of DNA damage that accumulates during cellular stress in the stationary phase."
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "llama-2-7b-chat-hf_response": "There are several computational tools available for the prediction of beta-barrel transmembrane proteins. Some of the commonly used tools include:\n1. TMHMM: A widely used tool for predicting the structure and function of transmembrane proteins. It uses a combination of sequence analysis and structure-based methods to predict the transmembrane helices and the orientation of the protein in the membrane.\n2. SignalP: A tool for predicting the presence and location of signal peptides in a protein sequence. Signal peptides are the regions of a protein that direct its transport across the membrane, and the prediction of these regions can help identify beta-barrel transmembrane proteins.\n3. PredictProtein: A tool that uses a combination of sequence analysis and machine learning algorithms to predict the structure and function of a protein. It can predict the transmembrane helices and the orientation of the protein in the membrane, as well as other features such as the presence of signal peptides and the location of the active site.\n4. TMGMM: A tool that uses a combination of sequence analysis and structure-based methods to predict the transmembrane helices and the orientation of the protein in the membrane. It also predicts the presence of potential membrane-spanning segments and the location of the active site.\n5. PHD: A tool that uses a combination of sequence analysis and machine learning algorithms to predict the structure and function of a protein. It can predict the transmembrane helices and the orientation of the protein in the membrane, as well as other features such as the presence of signal peptides and the location of the active site.\n6. BepiPred: A tool that uses a combination of sequence analysis and structure-based methods to predict the transmembrane helices and the orientation of the protein in the membrane. It also predicts the presence of potential membrane-spanning segments and the location of the active site.\n7. TMPro: A tool that uses a combination of sequence analysis and machine learning algorithms to predict the structure and function of a protein. It can predict the transmembrane helices and the orientation of the protein in the membrane, as well as other features such as the presence of signal peptides and the location of the active site.\n8. SOSUI: A tool that uses a combination of sequence analysis and structure-"
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "llama-2-7b-chat-hf_response": "Galassi classification is used to classify individuals with intellectual disability (ID) based on the severity of their cognitive and adaptive functioning deficits. It is used to determine the level of support and services an individual may require to live independently or with minimal support. The Galassi classification system includes three categories:\n1. Mild ID: Individuals with mild ID have cognitive and adaptive functioning deficits that do not significantly impact their daily functioning.\n2. Moderate ID: Individuals with moderate ID have cognitive and adaptive functioning deficits that impact their daily functioning, but they are able to perform most tasks with some support.\n3. Severe ID: Individuals with severe ID have significant cognitive and adaptive functioning deficits that significantly impact their daily functioning and require extensive support and accommodations to live independently."
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "llama-2-7b-chat-hf_response": "Shapiro syndrome, also known as Shapiro-Omenn syndrome, is a rare genetic disorder that affects the development of the eyes, ears, and other organs. Here are some common features of Shapiro syndrome:\n1. Congenital cataracts: Most individuals with Shapiro syndrome are born with cataracts, which are cloudy areas in the lens of the eye that can impair vision.\n2. Microphthalmia: People with Shapiro syndrome typically have small eyes, which can lead to vision problems.\n3. Anophthalmia: In some cases, individuals with Shapiro syndrome may be born without one or both eyes.\n4. Hearing loss: Shapiro syndrome can cause hearing loss, which can range from mild to severe.\n5. Cerebellar hypoplasia: The cerebellum is the part of the brain that coordinates movement and balance. In Shapiro syndrome, the cerebellum may be smaller than usual, which can lead to coordination problems and movement disorders.\n6. Intellectual disability: Individuals with Shapiro syndrome may have mild to moderate intellectual disability.\n7. Distinctive facial features: People with Shapiro syndrome may have distinctive facial features, including a small head, narrow eyes, and a short nose.\n8. Skeletal abnormalities: Shapiro syndrome can cause various skeletal abnormalities, including short stature, joint deformities, and extra or missing ribs.\n9. Heart defects: Some individuals with Shapiro syndrome may have heart defects, such as ventricular septal defect or atrial septal defect.\n10. Other abnormalities: Shapiro syndrome can also cause various other abnormalities, including kidney problems, gastrointestinal issues, and developmental delays.\nIt's important to note that the severity and specific features of Shapiro syndrome can vary widely between individuals, and some people may have a milder or more severe form of the disorder. A diagnosis of Shapiro syndrome is typically made through a combination of clinical evaluation, genetic testing, and imaging studies."
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "llama-2-7b-chat-hf_response": "BRAG1 (BRAG-1-related gene 1) is linked to several diseases, including:\n1. Brag1 syndrome: A rare genetic disorder characterized by growth retardation, intellectual disability, and facial dysmorphism.\n2. Cerebral cavernous malformations (CCMs): Mutations in BRAG1 have been identified as a cause of some forms of CCMs, which are abnormalities in the brain that can cause seizures, stroke-like episodes, and other neurological problems.\n3. Neurofibromatosis type 1 (NF1): BRAG1 mutations have been identified in some cases of NF1, a genetic disorder that can cause various symptoms including benign tumors on the skin, optic nerve gliomas, and other neurological problems."
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "llama-2-7b-chat-hf_response": "The main inhibitor of protein phosphatase 1 (PP1) is called PP1-specific inhibitor 1 (PIN1)."
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "llama-2-7b-chat-hf_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, in Bacillus subtilis involves the increased mutation rate of the bacterial genome during stationary phase, which is characterized by limited nutrient availability and high stress levels. The underlying mechanisms include:\n1. DNA damage response: The increased mutation rate during stationary phase may be due to the activation of the DNA damage response, which involves the repair of DNA damage through mutagenic processes such as base excision repair and mutL mutS homologous recombination.\n2. Reactive oxygen species (ROS) production: Stationary-phase bacteria produce high levels of ROS, which can directly damage DNA and lead to mutations.\n3. Mismatch repair deficiency: The stationary-phase mutator phenotype is often associated with mutations in genes involved in mismatch repair, such as mutS and mutL.\n4. Telomere shortening: Telomeres, the repetitive DNA sequences that cap the ends of chromosomes, shorten during stationary phase. This can lead to the activation of the SOS response, which can result in mutations.\n5. Transcriptional interference: During stationary phase, the expression of certain genes can interfere with the transcription of other genes, leading to mutations.\n6. Epigenetic changes: Stationary-phase bacteria may experience epigenetic changes, such as alterations in DNA methylation or histone modification, which can affect gene expression and lead to mutations.\n7. Genome instability: Stationary-phase bacteria may have a higher genome instability due to the accumulation of mutations in genes involved in DNA repair and maintenance, leading to a higher mutation rate.\n8. Error-prone DNA repair: Stationary-phase bacteria may use error-prone DNA repair pathways, such as nucleotide excision repair, which can lead to mutations.\n9. Chromosomal rearrangements: Stationary-phase bacteria may undergo chromosomal rearrangements, such as chromosome fragmentation or chromosome loss, which can lead to mutations.\n10. Horizontal gene transfer: Stationary-phase bacteria may undergo horizontal gene transfer"
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "llama-2-7b-chat-hf_response": "Erucism, also known as erucismatosis or eruptions of the skin, can be caused by a variety of factors, including:\n1. Allergies: Eruptions on the skin can be triggered by allergies to certain substances, such as plants, medications, or insect bites.\n2. Infections: Bacterial, fungal, or viral infections can cause eruptions on the skin.\n3. Autoimmune disorders: Conditions such as psoriasis, eczema, and lupus can cause eruptions on the skin.\n4. Genetic disorders: Certain genetic disorders, such as x-linked epidermolysis bullosa, can cause eruptions on the skin.\n5. Hormonal changes: Hormonal changes, such as those that occur during pregnancy or menopause, can cause eruptions on the skin.\n6. Medications: Certain medications, such as antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and blood pressure medications, can cause eruptions on the skin as a side effect.\n7. Environmental factors: Exposure to sunlight, wind, and cold weather can cause eruptions on the skin.\n8. Nutritional deficiencies: Deficiencies in certain nutrients, such as vitamin B12 or zinc, can cause eruptions on the skin.\n9. Skin injuries: Injuries to the skin, such as burns or cuts, can cause eruptions on the skin.\n10. Cancer: In rare cases, eruptions on the skin can be a symptom of skin cancer, such as melanoma.\nIt's important to note that this is not an exhaustive list and there may be other causes of erucism not mentioned here. If you are experiencing eruptions on your skin, it's important to see a dermatologist to determine the underlying cause and receive proper treatment."
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "llama-2-7b-chat-hf_response": "Hydrochlorothiazide is a diuretic medication that is commonly used to treat a variety of conditions, including:\n1. Hypertension (high blood pressure): Hydrochlorothiazide is used to treat mild to moderate hypertension, as it helps to reduce blood pressure by increasing urine production.\n2. Heart failure: Hydrochlorothiazide can help to reduce fluid buildup in the body, which can occur in heart failure patients.\n3. Edema (swelling): Hydrochlorothiazide is used to treat edema (swelling) caused by fluid buildup in the body, which can occur in conditions such as liver disease, kidney disease, or cancer.\n4. Nephrotic syndrome: Hydrochlorothiazide can help to reduce proteinuria (excess protein in the urine) in patients with nephrotic syndrome.\n5. Diabetes insipidus: Hydrochlorothiazide can help to treat diabetes insipidus, a condition that causes the body to produce too much urine.\n6. Urinary tract infections: Hydrochlorothiazide can help to treat urinary tract infections by increasing urine production and flushing out bacteria from the urinary tract.\n7. Cystitis: Hydrochlorothiazide can help to treat cystitis, a bladder infection caused by bacteria.\n8. Overactive bladder: Hydrochlorothiazide can help to treat overactive bladder, a condition characterized by sudden, intense need to urinate, and urgency to urinate.\nIt is important to note that hydrochlorothiazide can have side effects, such as electrolyte imbalances, and it may interact with other medications. Therefore, it is important to use hydrochlorothiazide only as directed by a healthcare professional."
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "llama-2-7b-chat-hf_response": "Yes, silicon has been used in the treatment of urinary incontinence. Silicon-based materials, such as silicon gel or silicon foam, have been used to create implantable devices that can help strengthen the muscles in the pelvic floor, which can help improve bladder control and reduce the risk of incontinence. These devices are typically used in cases of stress urinary incontinence, which is the most common type of incontinence in women.\nSilicon-based devices work by providing support to the urethral sphincter, the muscle that controls the flow of urine. By providing this support, the devices can help improve the function of the urethral sphincter and reduce the risk of incontinence. These devices are typically implanted through a minimally invasive surgical procedure and can be effective in improving bladder control and reducing the risk of incontinence in women.\nIt is important to note that silicon-based devices are not suitable for everyone and the decision to undergo this type of treatment should be made in consultation with a healthcare provider. Additionally, there may be other treatment options available, such as physical therapy or medication, that may be more appropriate for some individuals."
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "llama-2-7b-chat-hf_response": "There is a controversial association between the moon cycle and the risk of rupture of intracranial aneurysms. Some studies have suggested that the incidence of aneurysm rupture may increase during the full moon, while others have found no correlation. The exact mechanism behind this association is not fully understood, but it is thought that changes in blood pressure and cerebral vasospasm may play a role. However, the evidence is mixed and more research is needed to confirm or refute this association."
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "llama-2-7b-chat-hf_response": "Yes, the HuR protein (also known as ELAVL1) regulates the splicing process by binding to specific pre-mRNAs and modulating their splicing patterns. HuR is a member of the ELAVL (ELAV-like RNA-binding) family of proteins, which are involved in the regulation of mRNA metabolism, including splicing, transport, and stability.\nHuR recognizes and binds to specific introns and exons in pre-mRNAs, particularly those containing a conserved sequence motif called the ELAVL-binding element (EBE). By binding to these sequences, HuR can either enhance or suppress the splicing of specific exons, leading to changes in the final mRNA product.\nHuR has been implicated in the regulation of a wide range of genes involved in various cellular processes, including cell proliferation, differentiation, and survival. Dysregulation of HuR has been implicated in various diseases, including cancer and neurodegenerative disorders, highlighting its potential as a therapeutic target for these conditions."
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "llama-2-7b-chat-hf_response": "Prothymosin alpha (ProT) is a protein that plays a crucial role in the regulation of various cellular processes, including cell proliferation, differentiation, and survival. The c-terminal peptide of ProT, also known as ProT-CT, has been shown to have a number of distinct functions:\n1. Cell cycle regulation: ProT-CT can inhibit the progression of cells through the G1/S phase transition of the cell cycle and induce cell cycle arrest in G2/M phase.\n2. Apoptosis: ProT-CT can induce apoptosis (programmed cell death) in response to various stimuli, including oxidative stress and DNA damage.\n3. Anti-inflammatory effects: ProT-CT has been shown to inhibit the production of pro-inflammatory cytokines and chemokines, such as TNF-alpha and IL-8, in response to inflammatory stimuli.\n4. Neuroprotection: ProT-CT has been shown to protect against neurodegeneration in various animal models of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.\n5. Cardiovascular protection: ProT-CT has been shown to protect against cardiovascular damage in various animal models of cardiovascular disease, including hypertension and atherosclerosis.\n6. Anti-cancer effects: ProT-CT has been shown to inhibit the growth and survival of various types of cancer cells, including breast, lung, and colon cancer cells.\nOverall, the c-terminal peptide of ProT has a wide range of biological activities that are involved in the regulation of various cellular processes, and it has potential as a therapeutic agent for the treatment of various diseases, including cancer, neurodegenerative diseases, and cardiovascular disease."
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "llama-2-7b-chat-hf_response": "The peptide that plays a pivotal role in human cystatin C fibrillization is the N-terminal peptide (residues 1-13) of human cystatin C."
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1α increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "llama-2-7b-chat-hf_response": "Yes, the concentration of protein HIF-1α (hypoxia-inducible factor-1 alpha) increases after the administration of the cytoprotective prodrug ethyol (amifostine). HIF-1α is a transcription factor that plays a critical role in response to hypoxia and is involved in the regulation of various cellular processes, including cell survival, angiogenesis, and glucose metabolism. Ethyol is a prodrug that is converted to the active compound ethylene diamine (EDA), which has been shown to activate the PI3K/Akt signaling pathway, leading to the increase in HIF-1α protein levels."
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "llama-2-7b-chat-hf_response": "Set7 is a histone methyltransferase that deposits histone 3 lysine 4 trimethylation (H3K4me3) marks on histone proteins."
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "llama-2-7b-chat-hf_response": "The protein hepcidin has 4 disulfide bridges."
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "llama-2-7b-chat-hf_response": "The protein encoded by the gene DNAJC11 is a cytoplasmic protein."
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "llama-2-7b-chat-hf_response": "Yes, ultraconserved elements (UCEs) are depleted among copy number variants (CNVs). UCEs are sequences that are highly conserved across species and are thought to be important for regulating gene expression. CNVs, on the other hand, are genomic regions that contain extra or missing copies of DNA sequences, which can lead to changes in gene expression and other genomic effects.\nStudies have shown that UCEs are enriched in the regions of the genome that are not affected by CNVs, while CNVs are more likely to occur in regions that are less conserved and have lower UCE content. This suggests that UCEs may play a role in protecting against the disruption of gene expression caused by CNVs.\nAdditionally, a study published in the journal Nature in 2015 found that UCEs are more likely to be located in regions of the genome that are in close proximity to genes, and that these regions are also more likely to be affected by CNVs. This suggests that UCEs may play a role in protecting against the disruption of gene expression caused by CNVs by acting as a buffer zone around genes.\nIn summary, UCEs are depleted among CNVs, and this depletion may be due to the fact that UCEs are more likely to be located in regions of the genome that are in close proximity to genes, which are more likely to be affected by CNVs."
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "llama-2-7b-chat-hf_response": "Has2 (Haspin) is a kinase that plays a crucial role in regulating the progression of mitosis by phosphorylating and inhibiting the activity of the separin protein. The substrate of Has2 (Haspin) during mitosis is separin."
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "llama-2-7b-chat-hf_response": "Viroids are small, single-stranded RNA molecules that replicate through a mechanism that is distinct from other RNA viruses. They do not have a protein coat or a host cell machinery to replicate, but instead, they replicate through a process called \"rolling circle replication\".\nDuring rolling circle replication, the viroid RNA acts as both the template and the replication intermediate. The RNA molecule is circularized, and the replication machinery unwinds the RNA and synthesizes a new complementary strand. This process results in the production of multiple copies of the original RNA molecule, which can then go on to infect other cells.\nIn addition to rolling circle replication, some viroids have been shown to use a process called \"RNA-dependent RNA polymerase-mediated replication\" to replicate their genome. This process involves the use of an RNA-dependent RNA polymerase enzyme to synthesize a new complementary strand of RNA from the template RNA.\nOverall, the mechanisms of viroid replication are complex and not fully understood, and further research is needed to elucidate the details of this process."
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "llama-2-7b-chat-hf_response": "Yes, fibronectin has been identified as a potential serum biomarker for Duchenne muscular dystrophy (DMD). Studies have shown that levels of fibronectin in the bloodstream are significantly lower in individuals with DMD compared to healthy controls, and this reduction can be detected as early as 6 months of age. This decrease in fibronectin levels may serve as an early diagnostic marker for DMD and could potentially be used in conjunction with other biomarkers to improve the accuracy of diagnosis. Additionally, fibronectin levels have been shown to be associated with disease progression and muscle strength in DMD, making it a useful marker for monitoring disease severity and treatment response."
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "llama-2-7b-chat-hf_response": "DeepBlue is an epigenomic data server that contains data from several major epigenome projects, including:\n1. The ENCODE ( Encyclopedia of DNA Elements) project: This project aims to create a comprehensive catalog of all the functional elements in the human genome.\n2. The Roadmap Epigenomics Project: This project is focused on understanding the epigenetic changes that occur during development and disease, and has generated epigenetic data for multiple tissues and cell types.\n3. The Human Epigenome Project: This project aims to generate comprehensive epigenetic profiles for all human tissues and cells, and has generated data for over 100 different tissues and cell types.\n4. The Mouse Epigenome Project: This project aims to generate a comprehensive epigenetic map of the mouse genome, and has generated data for multiple tissues and cell types.\n5. The Epigenomics of Disease Project: This project aims to understand the epigenetic changes that occur in disease, and has generated epigenetic data for a variety of diseases, including cancer, diabetes, and neurological disorders.\nThese projects have generated a vast amount of epigenetic data, including DNA methylation, histone modification, and chromatin structure data, among others. The data from these projects are contained in the DeepBlue epigenomic data server and are available for analysis and integration with other datasets."
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "llama-2-7b-chat-hf_response": "The tool that employs self-organizing maps (SOM) for analyzing synonymous codon usage is called \"CodonUsage\"."
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "llama-2-7b-chat-hf_response": "MINDY-1 (Microtubule-Associated Protein 1 Light Chain 1, also known as EB1) is a protein that plays a crucial role in the regulation of microtubule dynamics and cellular behavior, particularly in the context of cancer. It is a plus-end tracking protein that binds to the plus ends of microtubules and regulates their stability and dynamics. MINDY-1 has been shown to be overexpressed in various types of cancer, and its overexpression has been linked to cancer progression and poor prognosis. Inhibition of MINDY-1 has been proposed as a potential therapeutic strategy for cancer treatment."
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "llama-2-7b-chat-hf_response": "There are several software packages available for the analysis of conserved genomic loci, including:\n1. MACS (Multiple Alignment of Conserved Sequences): This package uses a Hidden Markov Model (HMM) to identify conserved regions in multiple alignments of genomic sequences.\n2. MEME (Motif Explorer): This package uses a position-specific scoring matrix (PSSM) to identify conserved motifs in a multiple alignment of genomic sequences.\n3. HMMER: This package uses a HMM to identify conserved regions in a multiple alignment of genomic sequences.\n4. GERP (Genomic Expectation-Maximization for Repeats Prediction): This package uses a probabilistic model to identify conserved regions in a multiple alignment of genomic sequences.\n5. RepeatMasker: This package uses a combination of sequence similarity and genomic context to identify repetitive elements in a genome, including conserved regions.\n6. Prodigal: This package uses a Bayesian approach to identify conserved regions in a multiple alignment of genomic sequences.\n7. MUSCLE (Multiple Sequence Comparison by Log-Expectation): This package uses a multiple sequence alignment method to identify conserved regions in a multiple alignment of genomic sequences.\n8. RAxML (Raxml): This package uses a maximum likelihood approach to identify conserved regions in a multiple alignment of genomic sequences.\n9. BEAST (Bayesian Evolutionary Analysis by Sampling Trees): This package uses a Bayesian approach to identify conserved regions in a multiple alignment of genomic sequences.\n10. PhyloBayes (Phylogenetic Bayesian Analysis): This package uses a Bayesian approach to identify conserved regions in a multiple alignment of genomic sequences, and also infer the phylogenetic relationships among the sequences.\nIt's worth noting that the choice of software package will depend on the specific requirements and goals of the analysis, as well as the complexity and size of the dataset."
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "llama-2-7b-chat-hf_response": "The PIEZO2 gene has been associated with several diseases, including:\n1. Hypertension: Mutations in the PIEZO2 gene have been found to be associated with essential hypertension, a condition characterized by high blood pressure that can increase the risk of heart disease, stroke, and other cardiovascular problems.\n2. Nephropathy: PIEZO2 mutations have also been linked to certain forms of kidney disease, including nephropathy, which is damage to the kidneys that can lead to kidney failure.\n3. Hearing loss: Some studies have suggested that PIEZO2 mutations may be associated with hearing loss, particularly in the high-frequency range."
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "llama-2-7b-chat-hf_response": "ERAP1-ERAP2 dimerization promotes the degradation of endogenous retroviral elements (ERVs) and other RNA substrates."
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "llama-2-7b-chat-hf_response": "R-spondin 1 and Noggin are two proteins that play important roles in the regulation of stem cell maintenance and differentiation in non-damaged gallbladders.\nR-spondin 1 is a secreted protein that functions as a ligand for the Wnt receptor ROR2, promoting the proliferation and maintenance of stem cells in the gallbladder. It also regulates the expression of genes involved in cell adhesion and migration.\nNoggin, on the other hand, is a secreted protein that inhibits the Wnt signaling pathway by binding to and neutralizing Wnt proteins. In non-damaged gallbladders, Noggin regulates the balance between Wnt signaling and the maintenance of stem cell self-renewal, ensuring the proper differentiation of gallbladder cells.\nTogether, R-spondin 1 and Noggin help maintain the stem cell pool in the gallbladder, ensuring the proper functioning of the organ and preventing aberrant cell growth and differentiation."
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "llama-2-7b-chat-hf_response": "Yes, NADPH oxidase 5 (NOX5) requires at least two subunits, p47phox and p67phox, to function properly. These subunits work together to generate reactive oxygen species (ROS) in the cell."
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "llama-2-7b-chat-hf_response": "Furin and hepcidin are connected in the regulation of iron metabolism. Furin is a protease that processes several iron-responsive proteins, including hepcidin, a hormone that regulates iron absorption and recycling in the body. Furin cleaves hepcidin to activate its biological activity, leading to decreased iron absorption and increased iron recycling, thereby maintaining iron homeostasis in the body."
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "llama-2-7b-chat-hf_response": "The largest metabolic gene cluster in yeast is the glycolysis-gluconeogenesis pathway, which consists of 13 genes."
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "llama-2-7b-chat-hf_response": "LIMT (Long Non-Coding RNA in Myeloid Lineage Transcription) is a long non-coding RNA (lncRNA) that plays a critical role in the regulation of myeloid cell differentiation and function. It is specifically expressed in myeloid cells, including granulocytes, monocytes, and macrophages, and has been shown to play a key role in the following processes:\n1. Myeloid cell differentiation: LIMT lncRNA regulates the expression of genes involved in myeloid cell differentiation, including the transcription factors PU.1 and GATA2.\n2. Immune response: LIMT lncRNA modulates the immune response by regulating the expression of genes involved in the production of cytokines and chemokines, such as TNF-alpha and CXCL10.\n3. Inflammation: LIMT lncRNA has been shown to regulate the production of pro-inflammatory cytokines, such as IL-6 and IL-8, in response to inflammatory stimuli.\n4. Cancer: LIMT lncRNA has been implicated in the development and progression of myeloid malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).\nOverall, the role of LIMT lncRNA is to regulate the expression of genes involved in myeloid cell differentiation, immune response, inflammation, and cancer, and its dysregulation has been implicated in a variety of diseases."
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "llama-2-7b-chat-hf_response": "There are several R packages and bioconductor packages that can be used for performing SNP (single nucleotide polymorphism) enrichment analysis. Some of the commonly used packages are:\n1. \"SNPs\" package: This package provides a comprehensive set of functions for SNP analysis, including enrichment analysis.\n2. \"MAS5\" package: This package is a widely used tool for SNP enrichment analysis and can be used to identify overrepresented SNPs in a set of genes.\n3. \"GSEA\" package: This package is a popular tool for gene set enrichment analysis, which can be used to identify overrepresented gene sets in a set of SNPs.\n4. \"ENSA\" package: This package provides a comprehensive set of functions for SNP enrichment analysis, including gene set enrichment analysis.\n5. \"SNPEnrich\" package: This package provides a simple and efficient way to perform SNP enrichment analysis using a variety of methods.\n6. \"SNPsifter\" package: This package provides a comprehensive set of functions for SNP analysis, including enrichment analysis.\n7. \"GenomicRanges\" package: This package provides a comprehensive set of functions for genomic range analysis, which can be used to identify overrepresented SNPs in a set of genes.\n8. \"GSEA2\" package: This package is a updated version of the popular GSEA package and provides improved performance and functionality for SNP enrichment analysis.\n9. \"SNPEnricher\" package: This package provides a comprehensive set of functions for SNP enrichment analysis, including gene set enrichment analysis.\n10. \"Genome-Wide Association Study\" (GWAS) package: This package provides a comprehensive set of functions for performing GWAS, which can be used to identify SNPs associated with a trait or disease.\nIt's worth noting that the choice of package will depend on the specific requirements of the analysis and the type of data being analyzed."
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "llama-2-7b-chat-hf_response": "Radial glial cells are intermediate progenitors that give rise to ependymal cells in the developing brain. The key players involved in radial glial specification to ependymal cells include:\n1. Notch signaling: Notch is a critical regulator of radial glial cell fate and differentiation. Notch signaling promotes the maintenance of radial glial cells and their specification to ependymal cells.\n2. Wnt/β-catenin signaling: Wnt/β-catenin signaling also plays a crucial role in radial glial cell fate determination and differentiation. Wnt/β-catenin signaling promotes the transition of radial glial cells to ependymal cells.\n3. Shh signaling: Shh signaling is also involved in the regulation of radial glial cell fate and differentiation. Shh signaling promotes the maintenance of radial glial cells and their specification to ependymal cells.\n4. BMP signaling: BMP signaling can also regulate radial glial cell fate and differentiation, promoting the transition of radial glial cells to ependymal cells.\n5. FGF signaling: FGF signaling can also play a role in radial glial cell fate determination and differentiation, promoting the transition of radial glial cells to ependymal cells.\nThese signaling pathways work together to regulate the specification of radial glial cells to ependymal cells during brain development."
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "llama-2-7b-chat-hf_response": "Triple negative gliomas are a type of glioma, which is a type of brain cancer, that are characterized by the lack of expression of certain proteins that are typically used as markers for glioma diagnosis and prognosis. These proteins include:\n* Tumor suppressor proteins, such as p53 and PTEN\n* Markers of glial cell lineage, such as GFAP and A2B5\n* Receptors and signaling proteins, such as EGFR and PDGFR\nThe absence of these proteins makes it difficult to classify triple negative gliomas into more specific subtypes, such as glioblastoma, astrocytoma, or oligodendroglioma, which are typically defined by their molecular and histological features. Triple negative gliomas are often aggressive and have a poor prognosis, with a five-year survival rate of around 20-30%."
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "llama-2-7b-chat-hf_response": "TOPAZ1 (Topoisomerase 2-associated protein 1) is a protein that plays a role in regulating the activity of topoisomerase II, an enzyme that relaxes supercoiled DNA. TOPAZ1 is a histone chaperone that interacts with topoisomerase II and helps to recruit it to specific genomic regions, where it can perform its enzymatic functions. TOPAZ1 is involved in various cellular processes, including DNA replication, repair, and transcription, and it has been implicated in various diseases, including cancer and neurodegenerative disorders."
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "llama-2-7b-chat-hf_response": "The gene that controls the expression of GATA-1 isoforms is the GATA-1 gene itself. GATA-1 is a transcription factor that is involved in the regulation of gene expression during hematopoiesis, and it has multiple isoforms that are produced through alternative splicing. The expression of these isoforms is controlled by the GATA-1 gene, which contains different exons that are spliced together to produce the different isoforms."
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "llama-2-7b-chat-hf_response": "MIRA-seq is a genomic technique used to study the regulation of gene expression at the level of RNA molecules. MIRA (Microarray for In situ RNA Analysis) is a method that allows for the analysis of RNA molecules in their native context within cells and tissues, without the need for RNA isolation or purification.\nIn MIRA-seq, cells or tissues are fixed and embedded in a matrix, and then probed with a microarray containing thousands of known RNA sequences. The array is then scanned to detect the presence and abundance of specific RNA molecules in the sample. This allows researchers to identify and quantify the expression of specific RNA transcripts in different cells or tissues, and to study the regulation of gene expression at the level of RNA molecules.\nMIRA-seq has several advantages over other methods for studying RNA expression, including its high sensitivity and resolution, its ability to detect rare or novel transcripts, and its ability to study RNA expression in a spatially-resolved manner. It has been used to study a wide range of biological processes, including development, cell differentiation, and disease progression."
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "llama-2-7b-chat-hf_response": "ARCALYST (rilonacept) is a prescription medication used to treat a rare genetic disorder called cryopyrin-associated periodic syndrome (CAPS) in adults and children aged 12 years and older. It is also used to treat a related disorder called pyogenic sterile arthritis (PSA) in adults and children aged 12 years and older. CAPS and PSA are caused by a deficiency of the enzyme NLRC4, which is involved in the regulation of inflammation. By replacing the missing enzyme, ARCALYST helps to reduce the symptoms of these disorders, which can include recurring fever, joint pain, and swelling."
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "llama-2-7b-chat-hf_response": "Robertsonian translocations involve the exchange of a segment of chromosomal material between two acrocentric chromosomes, which are characterized by their terminal centromere. The following are the human acrocentric chromosomes that can be involved in Robertsonian translocations:\n1. Chromosome 13\n2. Chromosome 14\n3. Chromosome 15\n4. Chromosome 21\nRobertsonian translocations involving these chromosomes can result in a variety of genetic disorders, including Down syndrome (trisomy 21), Turner syndrome (monosomy 45, X), and Klinefelter syndrome (XXY)."
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "llama-2-7b-chat-hf_response": "The R package \"survival\" could be used for the identification of pediatric brain tumors. This package provides functions for survival analysis, which can be used to analyze the time-to-event data (e.g. time to disease progression or death) in medical datasets, including those related to brain tumors.\nSome of the key functions in the \"survival\" package that could be used for identifying pediatric brain tumors include:\n* \"surv\": This function estimates the survival function, which describes the probability of surviving beyond a certain time point, given the time of diagnosis or other covariates.\n* \"failure\": This function estimates the failure time, which is the time of death or failure (e.g. disease progression) for a patient.\n* \"coxph\": This function fits a Cox proportional hazards model, which is a commonly used statistical model for survival analysis. The model estimates the effect of covariates on the hazard rate (i.e. the rate at which the event occurs over time), while controlling for other variables in the model.\n* \"rpart\": This function fits a recursive partitioning model, which is a type of decision tree that can be used to identify subgroups of patients with different survival outcomes.\nBy using these functions, researchers could analyze the time-to-event data for pediatric brain tumors and identify subgroups of patients with different survival outcomes, which could help inform personalized treatment strategies."
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "llama-2-7b-chat-hf_response": "No, NEMO (NF-κB essential modulator) is not a zinc finger protein. NEMO is a protein that plays a crucial role in the regulation of NF-κB (nuclear factor kappa B), a transcription factor that regulates inflammation and immune responses. While NEMO does contain some zinc finger-like domains, it is not primarily a zinc finger protein."
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "llama-2-7b-chat-hf_response": "Yes, TFIIS (Transcription Factor IIS) can affect nucleosome positioning. TFIIS is a transcription factor that plays a role in the initiation of transcription in eukaryotic cells, and it has been shown to interact with nucleosomes and influence their positioning on the DNA. TFIIS can bind to the nucleosomal DNA and help to displace the histone H3 lysine 9 dimethyl (H3K9me2) mark, which is typically associated with compacted chromatin and transcriptional repression. By displacing this mark, TFIIS can help to recruit RNA polymerase to the promoter region and facilitate the initiation of transcription."
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "llama-2-7b-chat-hf_response": "Origins of replication near yeast centromeres typically fire late in the cell cycle."
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "llama-2-7b-chat-hf_response": "Mammalian GA-sequences are characterized by the following properties:\n1. Long-range orientation: Mammalian GA-sequences are typically long-range oriented, meaning that they are oriented in the opposite direction to the major groove of the DNA molecule.\n2. High GC content: Mammalian GA-sequences have a high GC content (greater than 50%), which is higher than the average GC content of most other types of DNA sequences.\n3. High stability: Mammalian GA-sequences are highly stable and resistant to degradation, due to the presence of guanine and cytosine bases.\n4. Low melting temperature: The Tm (melting temperature) of mammalian GA-sequences is typically low, indicating that they are less stable and more prone to denaturation than other types of DNA sequences.\n5. High affinity for DNA-binding proteins: Mammalian GA-sequences have a high affinity for DNA-binding proteins, such as transcription factors and regulatory proteins, which can bind to these sequences and regulate gene expression.\n6. Important role in regulation of gene expression: Mammalian GA-sequences play an important role in the regulation of gene expression, particularly in the context of cellular differentiation and development.\n7. Widely distributed in mammalian genomes: Mammalian GA-sequences are found throughout the mammalian genome, and are particularly enriched in regions of the genome that are involved in regulation of gene expression.\n8. High degree of sequence variability: There is a high degree of sequence variability among mammalian GA-sequences, which allows for the creation of a diverse range of functional motifs and binding sites.\n9. Regulation of chromatin structure: Mammalian GA-sequences can also regulate chromatin structure, by influencing the positioning and organization of histone-modifying enzymes and other chromatin-associated proteins.\n10. Involvement in disease: Mammalian GA-sequences have been implicated in a number of diseases, including cancer and neurological disorders, although the exact mechanisms by which they contribute"
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "llama-2-7b-chat-hf_response": "According to the Ensembl database, there are 4 Groucho-related genes (GRG) contained in the mouse genome:\n1. Grm1 (Groucho-related gene 1)\n2. Grm2 (Groucho-related gene 2)\n3. Grm3 (Groucho-related gene 3)\n4. Grm4 (Groucho-related gene 4)\nNote: The number of GRG genes may vary depending on the source and method of annotation."
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "llama-2-7b-chat-hf_response": "RNA polymerase II subunit RPB1 (also known as RNA polymerase II subunit B1) carries the RNA cleavage activity."
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "llama-2-7b-chat-hf_response": "Ohdo syndrome is caused by mutations in the PTPN11 gene, which encodes the protein tyrosine phosphatase non-receptor type 11 (PTPN11). PTPN11 is a negative regulator of the RAS/MAPK signaling pathway, which is important for cell growth and differentiation. Mutations in the PTPN11 gene lead to the loss of PTPN11 function, resulting in the activation of the RAS/MAPK pathway and the development of Ohdo syndrome."
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "llama-2-7b-chat-hf_response": "The R/Bioconductor package \"psychgene\" has been developed for the analysis of psychiatric disease genes. It provides tools for the analysis of genetic data in psychiatric disorders, including gene-level association testing, gene-gene interaction analysis, and pathway analysis."
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "llama-2-7b-chat-hf_response": "The \"swirl sign\" is a clinical sign that can be observed in patients with intracerebral hemorrhage (ICH), which is a type of stroke caused by bleeding in the brain. The sign is characterized by a swirling or spiral pattern of brain tissue surrounding the site of the hemorrhage.\nThe swirl sign is typically seen on computed tomography (CT) or magnetic resonance imaging (MRI) scans of the brain, and is caused by the movement of the brain tissue due to the bleeding. The sign can be seen in the form of a spiral or wavy pattern, which can be quite distinctive and can help doctors to identify the location and extent of the hemorrhage.\nThe swirl sign is thought to occur due to the displacement of brain tissue caused by the bleeding, which can cause the tissue to move in a spiral or wavy pattern. This displacement can be caused by the direct pressure of the hemorrhage on the surrounding brain tissue, or by the movement of the blood in the brain vessels.\nThe swirl sign can be an important diagnostic clue in the evaluation of patients with ICH, as it can help doctors to identify the location and extent of the hemorrhage. However, it is not a definitive diagnostic sign, and other imaging findings, such as the location and size of the hemorrhage, the presence of edema, and the involvement of nearby structures, should also be taken into account in the diagnosis and management of ICH."
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "llama-2-7b-chat-hf_response": "Arabidopsis ROF1 (RNA polymerase II-associated factor 1) expression is induced by various environmental and developmental signals, including:\n1. Light: Light signals can induce ROF1 expression in Arabidopsis, particularly blue light.\n2. Temperature: High temperatures can also induce ROF1 expression in Arabidopsis.\n3. Water availability: ROF1 expression can be induced in response to drought stress in Arabidopsis.\n4. Hormones: ROF1 expression can be regulated by various hormones, including abscisic acid (ABA), ethylene, and cytokinin.\n5. Developmental cues: ROF1 expression can also be induced during specific stages of plant development, such as during seedling establishment or floral development."
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "llama-2-7b-chat-hf_response": "The most common cause of hereditary renal amyloidosis is the protein alpha-2-macroglobulin (A2M)."
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "llama-2-7b-chat-hf_response": "Yes, the proteome of the mouse hippocampus has been extensively analyzed using various proteomics techniques. The hippocampus is a complex brain structure involved in memory formation, spatial navigation, and emotion regulation, and its proteome has been studied in various contexts, including development, aging, and disease.\nSome of the key findings from these studies include:\n1. Identification of novel proteins: Many proteins have been identified in the mouse hippocampus for the first time, including proteins involved in synaptic plasticity, neurotransmission, and protein degradation.\n2. Alterations in protein expression: Studies have shown that the expression of certain proteins changes in the hippocampus under different conditions, such as aging, disease, or exposure to drugs. For example, some studies have found that the expression of the synaptic plasticity protein, Arc, decreases with age, while others have found that the expression of the inflammatory protein, TNF-alpha, increases in response to stress.\n3. Protein modification: The hippocampus is rich in post-translational modifications (PTMs), such as phosphorylation and ubiquitination, which play important roles in regulating protein function. Studies have identified many PTMs in the hippocampus, including those involved in synaptic plasticity and memory formation.\n4. Protein-protein interactions: The hippocampus is a complex tissue with many proteins interacting with each other to regulate synaptic plasticity and memory formation. Studies have identified many protein-protein interactions in the hippocampus, including those involving the N-methyl-D-aspartate (NMDA) receptor, the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, and the CaMKII (calcium/calmodulin-dependent protein kinase II) protein.\n5. Regulation of protein localization: The hippocampus is a dynamic tissue with proteins localizing to different subcellular regions to regulate synaptic plasticity and memory formation. Studies have identified many proteins that are localized to specific subcell"
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "llama-2-7b-chat-hf_response": "No, mouse chromosomes are not acrocentric. Acrocentric chromosomes are a type of chromosome found in some organisms, including some bacteria and fungi, where the centromere is located near the telomere, or the end of the chromosome. In contrast, mouse chromosomes are metacentric, meaning that the centromere is located near the center of the chromosome."
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "llama-2-7b-chat-hf_response": "One siRNA-based drug that is currently in clinical trials for the treatment of pancreatic cancer is ONC201. ONC201 is an siRNA-based drug that targets the gene PD-L1 (programmed death-ligand 1) and has shown promise in preclinical studies as a potential treatment for pancreatic cancer. It is being developed by OncoSec Medical Inc. and is currently being evaluated in Phase 1/2 clinical trials for the treatment of pancreatic cancer."
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "llama-2-7b-chat-hf_response": "The HPG (Heterochromatin Protein G) pore is a protein complex that regulates the transport of RNA polymerase II (RNAPII) and other proteins across the nuclear envelope in eukaryotic cells. It is composed of the HPG protein and its associated subunits, and it acts as a gatekeeper for RNAPII, allowing it to transcribe genes located in the nucleus while preventing it from accessing genes located in the cytoplasm. The HPG pore plays a critical role in regulating gene expression and ensuring proper cellular function."
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "llama-2-7b-chat-hf_response": "The 959 Nematode Genomes initiative is a large-scale effort to sequence and analyze the genomes of 959 species of nematodes, which are a group of microscopic worms that are important model organisms in biomedical research. The initiative was launched in 2015 and is led by the University of California, Riverside, in collaboration with several other institutions and organizations.\nNematodes are found in a wide range of environments, including soil, water, and plants, and they have evolved a variety of mechanisms to survive and reproduce in these environments. As a result, they have a wide range of biological functions and processes that are of interest to researchers, including the ability to:\n* Develop resistance to pesticides and other chemicals\n* Regulate plant growth and development\n* Interact with beneficial microorganisms in the soil\n* Cause plant diseases\n* Act as vectors of plant viruses\nThe 959 Nematode Genomes initiative aims to provide a comprehensive understanding of the genetic and genomic diversity of nematodes, and how this diversity relates to their biological functions and interactions with their environments. The project involves sequencing the genomes of 959 species of nematodes using a variety of high-throughput sequencing technologies, and analyzing the resulting data to identify genes, regulatory elements, and other features of interest.\nThe initiative is expected to provide significant insights into the biology and evolution of nematodes, and to have practical applications in areas such as agriculture, biotechnology, and human health. For example, the project could lead to the development of new pest management strategies that are based on a better understanding of the biology and genetics of nematode populations, and could also provide new insights into the biology of human diseases such as filariasis, which is caused by a nematode parasite."
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "llama-2-7b-chat-hf_response": "There are several R packages that have been developed for analyzing Non-invasive prenatal testing (NIPT) data. Some of the popular ones include:\n1. NIPT: This package provides a set of functions for analyzing NIPT data, including the calculation of various test statistics, visualization of results, and estimation of genetic risks.\n2. Prenat: This package provides functions for analyzing NIPT data, including the calculation of test statistics, visualization of results, and estimation of genetic risks. It also includes tools for working with prenatal data more generally.\n3. PregnancyTesting: This package provides functions for analyzing NIPT data, including the calculation of test statistics, visualization of results, and estimation of genetic risks. It also includes tools for working with pregnancy-related data more generally.\n4. NIPTworkflow: This package provides a workflow for analyzing NIPT data, including functions for data cleaning, preprocessing, and visualization.\n5. PrenatalGenetics: This package provides functions for analyzing NIPT data, including the calculation of test statistics, visualization of results, and estimation of genetic risks. It also includes tools for working with prenatal data more generally, such as calculating the risk of chromosomal abnormalities.\n6. PrenatGen: This package provides functions for analyzing NIPT data, including the calculation of test statistics, visualization of results, and estimation of genetic risks. It also includes tools for working with prenatal data more generally, such as calculating the risk of chromosomal abnormalities.\nThese packages can be used to perform various analyses on NIPT data, such as calculating the risk of genetic disorders, identifying high-risk pregnancies, and detecting chromosomal abnormalities."
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbach’s syndrome.",
    "llama-2-7b-chat-hf_response": "Achenbach's syndrome is a rare genetic disorder characterized by a variety of physical and developmental abnormalities. The main features of the syndrome include:\n1. Short stature: Individuals with Achenbach's syndrome are short-statured, with an average height of around 4 feet (122 cm) or less.\n2. Brain abnormalities: The syndrome is associated with various brain abnormalities, including microcephaly (a small head), cerebral atrophy (reduced brain size), and abnormalities of the corpus callosum (the bundle of nerve fibers that connects the two hemispheres of the brain).\n3. Facial abnormalities: People with Achenbach's syndrome may have distinctive facial features, including a small head, narrow eyes, a short nose, and a wide mouth.\n4. Skeletal abnormalities: The syndrome can cause a range of skeletal abnormalities, including short limbs, ribcage deformities, and joint contractures (limited joint mobility).\n5. Neurological problems: Achenbach's syndrome can also cause a range of neurological problems, including seizures, intellectual disability, and problems with movement and coordination.\n6. Genetic mutations: Achenbach's syndrome is caused by mutations in the FGD1 gene, which is responsible for producing a protein involved in the development and maintenance of the nervous system.\n7. Autism-like features: Some individuals with Achenbach's syndrome may also exhibit autism-like behaviors, such as social and communication difficulties, and repetitive behaviors.\n8. Other symptoms: Other symptoms of Achenbach's syndrome can include delayed development, poor muscle tone, and vision and hearing problems.\nAchenbach's syndrome is a rare and complex disorder, and the symptoms can vary widely between individuals. The syndrome is usually diagnosed through a combination of clinical evaluation, imaging studies, and genetic testing. Treatment is focused on managing the symptoms and improving the quality of life for individuals with the syndrome."
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "llama-2-7b-chat-hf_response": "There are several algorithms used for the detection of long repeat expansions in genomic DNA, including:\n1. RepeatMasker: This algorithm uses a combination of sequence similarity and k-mer frequency to identify repetitive elements in a genome.\n2. GATK (Genome Analysis Toolkit): This software package includes a number of tools for repeat masking, including the \"RepeatMasker\" tool, which uses a combination of sequence similarity and k-mer frequency to identify repetitive elements in a genome.\n3. LD-Repeat: This algorithm uses a combination of sequence similarity and linkage disequilibrium (LD) to identify repetitive elements in a genome.\n4. RepeatAnalyzer: This tool uses a combination of sequence similarity and k-mer frequency to identify repetitive elements in a genome, and can also be used to predict the impact of repeat expansions on gene expression.\n5. Repetin: This algorithm uses a combination of sequence similarity and k-mer frequency to identify repetitive elements in a genome, and can also be used to predict the impact of repeat expansions on gene expression.\n6. Variance-Stabilizing Transform (VST): This algorithm uses a statistical technique called variance-stabilizing transform to identify repetitive elements in a genome.\n7. ClustalW: This algorithm uses a multiple sequence alignment tool to identify repetitive elements in a genome.\n8. HMMER: This algorithm uses a hidden Markov model (HMM) to identify repetitive elements in a genome.\n9. Prodigal: This algorithm uses a combination of sequence similarity and k-mer frequency to identify repetitive elements in a genome, and can also be used to predict the impact of repeat expansions on gene expression.\n10. RepeatScout: This algorithm uses a combination of sequence similarity and k-mer frequency to identify repetitive elements in a genome, and can also be used to predict the impact of repeat expansions on gene expression.\nIt's worth noting that the choice of algorithm will depend on the specific research question and the characteristics of the genomic data being analyzed."
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "llama-2-7b-chat-hf_response": "Neuroligin-3 has been shown to promote the growth and progression of certain types of brain tumors, including:\n1. Medulloblastoma: A type of pediatric brain cancer that originates in the cerebellum.\n2. Glioblastoma: The most common and aggressive type of adult brain cancer.\n3. Medullofibroma: A rare type of brain cancer that arises in the cerebellum.\nNeuroligin-3 has been shown to promote the growth and survival of cancer cells in these tumor types by modulating the PI3K/Akt signaling pathway and inhibiting the activity of the tumor suppressor protein, p53."
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "llama-2-7b-chat-hf_response": "Gas vesicles in bacteria are typically around 10-20 nanometers (nm) in diameter."
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "llama-2-7b-chat-hf_response": "BET (Bromodomain and Extra-Terminal) proteins are a family of proteins that play a crucial role in regulating gene expression by modulating the structure of chromatin. Here are the four known BET proteins:\n1. BET1 (Bromodomain-Containing Protein 1)\n2. BET2 (Bromodomain-Containing Protein 2)\n3. BET3 (Bromodomain-Containing Protein 3)\n4. BET4 (Bromodomain-Containing Protein 4)\nThese proteins are characterized by a bromodomain, a protein domain that recognizes and binds to acetylated lysine residues on histone proteins, leading to changes in chromatin structure and gene expression."
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "llama-2-7b-chat-hf_response": "One algorithm that has been developed for prediction of protein subcellular localization using deep learning is the \"DeepLoc\" algorithm. DeepLoc is a deep learning-based method that uses a convolutional neural network (CNN) to predict the subcellular localization of a protein based on its amino acid sequence. The algorithm was developed by Zhang et al. in 2018 and has been shown to outperform other state-of-the-art methods for protein localization prediction."
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "llama-2-7b-chat-hf_response": "MULTOVL is a protein that is involved in the regulation of mRNA splicing. It is a multivalent protein that binds to multiple sites on the pre-mRNA and regulates the splicing of specific exons."
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "llama-2-7b-chat-hf_response": "Yes, GDF15 (Growth Differentiation Factor 15) has been identified as a potential biomarker for metformin treatment. Studies have shown that GDF15 levels are increased in response to metformin treatment in patients with type 2 diabetes, and that high levels of GDF15 are associated with improved insulin sensitivity and glucose metabolism. Therefore, measuring GDF15 levels in the blood may be a useful way to monitor the effectiveness of metformin treatment and to identify patients who are likely to benefit from this drug."
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "llama-2-7b-chat-hf_response": "Yes, recursive splicing is more common in short introns. Recursive splicing, also known as intron circular splicing, occurs when the same intron is spliced back into the pre-mRNA after it has been excised, resulting in the formation of a circular splicing pattern. This type of splicing is more common in short introns, as the shorter distance between the intron and the exon boundaries makes it easier for the splicing machinery to recognize and re-splice the intron."
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "llama-2-7b-chat-hf_response": "TALE-iD is a method used for identifying the functional targets of transcription factors. It stands for \"Targeted Association and Localization of Transcription Factor-binding Elements by DNA sequencing.\" The method involves using DNA sequencing to identify the specific DNA sequences that are bound by a particular transcription factor, and then using this information to predict the functional targets of the transcription factor."
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "llama-2-7b-chat-hf_response": "There are several Lisp frameworks that have been developed for image processing, including:\n1. CL-Image: CL-Image is a Lisp image processing library that provides a variety of image processing functions, including filtering, resizing, and thresholding. It is written in Common Lisp and is designed to be easy to use and integrate into existing Lisp applications.\n2. ImageTk: ImageTk is a Lisp interface to the Tk image processing toolkit. It provides a set of functions for loading, manipulating, and saving images, as well as a number of image processing operations, such as filtering and resizing.\n3. Lisp-Image: Lisp-Image is a Lisp library for image processing that provides a simple and easy-to-use interface for loading, manipulating, and saving images. It includes a number of image processing functions, including filtering, resizing, and thresholding.\n4. Lisp-Image-Pro: Lisp-Image-Pro is a Lisp library for image processing that provides a comprehensive set of image processing functions, including filtering, resizing, and thresholding. It also includes a number of advanced features, such as support for multiple image formats and the ability to perform image registration.\n5. Image-Lisp: Image-Lisp is a Lisp library for image processing that provides a simple and easy-to-use interface for loading, manipulating, and saving images. It includes a number of image processing functions, including filtering, resizing, and thresholding, as well as support for multiple image formats.\nIt's worth noting that these are just a few examples of Lisp frameworks for image processing, and there may be others available depending on your specific needs and requirements."
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "llama-2-7b-chat-hf_response": "The yeast species Saccharomyces cerevisiae (baker's yeast) underwent a whole genome duplication (WGD) event about 1,000 million years ago, resulting in the duplication of approximately 80% of its genes. This means that about 600-700 genes in the S. cerevisiae genome are the result of this ancient WGD event."
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor β (Esrrb)?",
    "llama-2-7b-chat-hf_response": "Estrogen-related receptor β (Esrrb) binds to the nucleosome."
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "llama-2-7b-chat-hf_response": "ZCCHC17 is a zinc finger CCHC-type histone triad-containing protein that plays a role in the regulation of chromatin structure and gene expression. It is involved in the modulation of transcriptional elongation and the maintenance of genome stability, and has been implicated in various cellular processes, including cell proliferation, differentiation, and survival."
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "llama-2-7b-chat-hf_response": "The nuclear pore basket in human cells is composed of several proteins, including:\n1. Nucleoporin 1 (Nup1)\n2. Nucleoporin 2 (Nup2)\n3. Nucleoporin 3 (Nup3)\n4. Nucleoporin 4 (Nup4)\n5. Nucleoporin 5 (Nup5)\n6. Nucleoporin 6 (Nup6)\n7. Nucleoporin 7 (Nup7)\n8. Nucleoporin 8 (Nup8)\n9. Nucleoporin 9 (Nup9)\n10. Nucleoporin 10 (Nup10)\nThese proteins work together to form the nuclear pore complex (NPC), which is a large protein structure that spans the nuclear envelope and regulates the transport of molecules between the nucleus and the cytoplasm."
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "llama-2-7b-chat-hf_response": "Gepotidacin is a topoisomerase II inhibitor. Specifically, it is a topoisomerase II alpha (Topo IIα) inhibitor."
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "llama-2-7b-chat-hf_response": "Canvas SPW (Spatially-Aware Processing Workflow) is a computational framework designed to enable the efficient and scalable processing of large-scale spatial data, such as those generated by satellite imagery, LiDAR (Light Detection and Ranging), and other remote sensing technologies. Canvas SPW is specifically tailored to handle the unique challenges associated with processing and analyzing large-scale spatial data, including:\n1. Data heterogeneity: Canvas SPW can handle a wide range of spatial data formats and sources, including multi-modal data (e.g., image, LiDAR, and GIS data).\n2. Data complexity: Canvas SPW can efficiently process large-scale spatial data sets with complex geometry, such as those found in 3D city models, terrain models, and other geospatial data.\n3. Data distribution: Canvas SPW is designed to scale to large-scale distributed computing environments, allowing it to handle very large data sets that would be too large for a single machine or local cluster.\n4. Data quality: Canvas SPW provides a range of tools and techniques for data quality assessment and improvement, including data cleaning, filtering, and feature extraction.\n5. Data integration: Canvas SPW can integrate data from multiple sources and formats, enabling the creation of comprehensive and accurate spatial data sets.\n6. Data visualization: Canvas SPW includes a range of visualization tools for exploring and analyzing spatial data, including 2D and 3D visualization, and support for virtual reality (VR) and augmented reality (AR) applications.\n7. Data analytics: Canvas SPW provides a range of analytics tools for analyzing spatial data, including spatial statistics, machine learning, and data mining.\n8. Data sharing: Canvas SPW supports data sharing and collaboration, enabling researchers and practitioners to share and access spatial data sets and workflows.\nSome of the key features of Canvas SPW include:\n* A modular architecture that allows users to define and execute complex workflows.\n* Support for a wide range of spatial data formats and sources.\n* Efficient data processing and analysis tools, including spatial statistics, machine learning, and data mining.\n* A range of visualization tools for exploring and analyzing spatial data.\n* Support for"
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "llama-2-7b-chat-hf_response": "STING (STimulator of Interferon Genes) is a protein that plays a crucial role in the innate immune response to viral infections. STING agonists are molecules that activate STING and trigger the production of interferon, a potent antiviral molecule. Here are some examples of STING agonists:\n1. Poly (I:C): Poly (I:C) is a synthetic analog of viral double-stranded RNA that activates STING and induces the production of interferon.\n2. CpG DNA: CpG DNA is a type of DNA found in the genomes of bacteria and viruses that contains the dinucleotide CpG. CpG DNA activates STING and induces the production of interferon.\n3. DNA-based vaccines: Some DNA-based vaccines, such as the HPV vaccine, have been shown to activate STING and induce the production of interferon.\n4. Small molecule agonists: Small molecule agonists of STING, such as GSK872, have been developed as potential therapeutics for the treatment of a variety of diseases, including cancer and viral infections.\n5. Peptide agonists: Some peptide molecules, such as STING-activating peptide (SAP), have been shown to activate STING and induce the production of interferon.\n6. Viral mimics: Some viral mimics, such as the Toll-like receptor (TLR) agonist, poly (I:C), have been shown to activate STING and induce the production of interferon.\n7. Imidazolediones: Imidazolediones, such as imidazole-4-acetamide (I4A), are small molecules that activate STING and induce the production of interferon.\n8. Quinacrine: Quinacrine is a small molecule that activates STING and induces the production of interferon.\nThese are just a few examples of STING agonists, and there are likely many more molecules that can activate"
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "llama-2-7b-chat-hf_response": "SLIC-CAGE (Slicing-based Chromatin Accessibility Genome Engineering) is a genome engineering technology that allows for the precise modification of chromatin structure and accessibility. It is based on the CRISPR-Cas13 system, which is a type of RNA-guided DNA endonuclease that can be programmed to recognize specific DNA sequences and cleave them.\nIn the SLIC-CAGE system, the CRISPR-Cas13 enzyme is used to introduce specific double-strand breaks (DSBs) in the genome at desired locations. These DSBs can then be repaired by the cell's own repair machinery, leading to the creation of specific chromatin modifications.\nThe SLIC-CAGE system takes advantage of the fact that the repair of DSBs can result in the formation of chromatin loops, which are higher-order chromatin structures that can bring distant regulatory elements into close proximity to their target genes. By targeting the CRISPR-Cas13 enzyme to specific regulatory regions of the genome, the SLIC-CAGE system can create specific chromatin modifications that can alter gene expression levels or chromatin structure.\nThe SLIC-CAGE system has a number of potential applications in gene therapy, including the treatment of genetic diseases caused by chromatin mutations, and the modification of gene expression levels in cancer cells. It is a relatively new technology, and further research is needed to fully understand its mechanisms and potential uses."
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "llama-2-7b-chat-hf_response": "LEM-3 is a protein that plays several roles in the cell, including:\n1. Chromatin remodeling: LEM-3 is a member of the LEM (lin-11, emerin, and muf1) protein family, which are involved in the remodeling of chromatin structure.\n2. Nuclear envelope maintenance: LEM-3 is also involved in the maintenance of the nuclear envelope, which is the membrane that surrounds the nucleus in eukaryotic cells.\n3. Cell cycle regulation: LEM-3 has been shown to play a role in the regulation of the cell cycle, particularly in the G2/M phase transition.\n4. Apoptosis: LEM-3 has been implicated in the regulation of programmed cell death (apoptosis), particularly in the context of cancer.\n5. Nuclear localization: LEM-3 is localized to the nucleus in most cell types, where it plays a role in the regulation of various nuclear processes."
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "llama-2-7b-chat-hf_response": "As a helpful assistant, I'm happy to provide you with the releases of the tmVar package in R:\n1.0.0 (2018-06-01) - The first release of tmVar, which introduces the basic functionality for variable transformation.\n1.2.0 (2018-12-01) - The second release of tmVar, which adds new methods for transforming variables, including the ability to transform variables with multiple dimensions.\n1.3.0 (2019-06-01) - The third release of tmVar, which introduces a new method for transforming variables with complex structures, such as matrices and data frames.\n1.4.0 (2020-02-01) - The fourth release of tmVar, which adds new functionality for working with time series data and improves the performance of the package.\n1.5.0 (2020-06-01) - The fifth release of tmVar, which introduces a new method for transforming variables using a Bayesian approach and improves the documentation of the package.\nNote that these are the major releases of the tmVar package, and there may be minor releases with bug fixes and other improvements in between."
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "llama-2-7b-chat-hf_response": "There is no single database of somatic mutations in normal cells. Somatic mutations are mutations that occur in non-reproductive cells in a tissue or organism, and they can occur in both cancerous and non-cancerous cells.\nHowever, there are several databases that contain information on somatic mutations in various types of cells, including:\n1. The Cancer Genome Atlas (TCGA): TCGA is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) that aims to catalogue the genomic changes in various types of cancer. The database contains RNA sequencing data, DNA mutation data, and clinical information for thousands of cancer samples.\n2. The ExAC (Exome Aggregation Consortium) database: The ExAC database is a collection of exome sequencing data from over 60,000 individuals, including both cancerous and non-cancerous samples. The database contains information on somatic mutations in exons, as well as information on the frequency and distribution of these mutations in the general population.\n3. The COSMIC (Catalogue of Somatic Mutations in Cancer) database: COSMIC is a comprehensive database of somatic mutations found in various types of cancer. The database contains information on both point mutations and structural variations, as well as information on the frequency and distribution of these mutations in different cancer types.\n4. The MutSig database: MutSig is a database of somatic mutations found in cancer genomes, including both exonic and non-exonic mutations. The database contains information on the frequency and distribution of these mutations in different cancer types, as well as information on their potential functional impact.\n5. The Cancer Mutation Hotspot Database (CMHD): CMHD is a database of somatic mutations found in cancer genomes, including both point mutations and structural variations. The database contains information on the frequency and distribution of these mutations in different cancer types, as well as information on their potential functional impact.\nThese are just a few examples of the many databases that contain information on somatic mutations in normal cells. Each database has its own specific focus and scope, and they may contain different types of data and different levels of detail."
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "llama-2-7b-chat-hf_response": "Yes, there are several graph kernel libraries available that have been implemented in Java. Here are some examples:\n1. JGraphT: JGraphT is a Java library for creating and manipulating graphs. It provides a simple API for creating graphs, adding vertices and edges, and performing graph operations such as traversals and shortest paths.\n2. GraphBLAS: GraphBLAS is a high-performance graph processing library that provides a set of linear algebra operations for graphs. It includes a Java implementation of the GraphBLAS library, which can be used to perform graph computations on large graphs.\n3. Weave: Weave is a Java library for graph processing that provides a simple API for creating and manipulating graphs. It includes a number of graph algorithms and data structures, including graphs, trees, and hierarchical graphs.\n4. GraphCrunch: GraphCrunch is a Java library for graph processing that provides a simple API for creating and manipulating graphs. It includes a number of graph algorithms and data structures, including graphs, trees, and hierarchical graphs.\n5. GraphXR: GraphXR is a Java library for graph processing that provides a simple API for creating and manipulating graphs. It includes a number of graph algorithms and data structures, including graphs, trees, and hierarchical graphs.\n6. JGraph: JGraph is a Java library for creating and manipulating graphs. It provides a simple API for creating graphs, adding vertices and edges, and performing graph operations such as traversals and shortest paths.\n7. GraphMol: GraphMol is a Java library for molecular graph algorithms. It provides a simple API for creating and manipulating molecular graphs, and includes a number of algorithms for working with molecular graphs.\n8. JGraphT-Ext: JGraphT-Ext is an extension of the JGraphT library that provides additional functionality for working with large graphs. It includes a number of algorithms for working with large graphs, including graph partitioning and graph clustering.\nThese are just a few examples of the many graph kernel libraries available in Java. Each library has its own strengths and weaknesses, and the best library for a particular application will depend on the specific requirements of the project."
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "llama-2-7b-chat-hf_response": "The SHERLOCKv2 platform integrates four advances in molecular diagnostics:\n1. CRISPR-Cas12a: SHERLOCKv2 uses CRISPR-Cas12a as the nucleic acid sensing component, which is a type of RNA-guided endonuclease that can detect specific RNA sequences with high sensitivity and specificity.\n2. Multiplexing: SHERLOCKv2 allows for the simultaneous detection of multiple targets by using different guide RNAs (gRNAs) that are designed to recognize different target RNAs. This enables the detection of multiple pathogens or biomarkers in a single reaction.\n3. Reporter genes: SHERLOCKv2 uses a reporter gene, such as luciferase or GFP, to indicate the presence of the target RNA. This allows for the detection of the target RNA to be visualized and quantified in a simple and efficient manner.\n4. Digital PCR: SHERLOCKv2 uses digital PCR (dPCR) to quantify the amount of the target RNA in the sample. dPCR is a highly accurate and sensitive method for quantifying nucleic acid sequences, and it allows for the detection of very low levels of target RNA in a sample."
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "llama-2-7b-chat-hf_response": "The Bartender algorithm is a machine learning algorithm used for feature selection and dimensionality reduction in datasets. It was introduced by Tanaka et al. in 2008. The algorithm is designed to identify the most informative features in a dataset and to reduce the dimensionality of the data while preserving the information content of the original features.\nThe Bartender algorithm works by treating the feature selection problem as a optimization problem. The objective function is defined as the log-likelihood of the training data given the selected features, and the algorithm minimizes this function using an iterative algorithm. The algorithm starts with an initial set of features and iteratively adds or removes features until the optimal set of features is obtained.\nThe key steps of the Bartender algorithm are:\n1. Initialize the set of features: The algorithm starts with an initial set of features, which may be all the features in the dataset.\n2. Calculate the log-likelihood: The algorithm calculates the log-likelihood of the training data given the current set of features.\n3. Evaluate the features: The algorithm evaluates each feature in the current set based on its information content, which is measured using the Shannon entropy.\n4. Select the most informative features: The algorithm selects the top-ranked features based on their information content and adds them to the set of selected features.\n5. Repeat steps 2-4: The algorithm repeats steps 2-4 until a stopping criterion is reached, such as a maximum number of iterations or a minimum level of improvement in the log-likelihood.\n6. Output the selected features: The final selected features are output, which can be used for further analysis or modeling.\nThe Bartender algorithm has several advantages over other feature selection algorithms, including:\n* It can handle high-dimensional datasets: The algorithm can handle datasets with a large number of features, making it useful for datasets with a large number of potential features.\n* It can identify non-linear relationships: The algorithm can identify non-linear relationships between the features and the target variable, which can lead to better performance in machine learning tasks.\n* It can handle missing values: The algorithm can handle missing values in the dataset, which can be a common problem in many machine learning tasks.\n* It is easy to implement: The algorithm is relatively simple to implement, and the computational cost is low, making it a good choice for large datasets.\nHowever"
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "llama-2-7b-chat-hf_response": "There are several web-based pedigree editors available, including:\n1. Pedigree Online: This is a popular web-based platform for creating and managing family trees. It offers features such as personalized profiles, ancestry charts, and collaboration tools.\n2. MyHeritage: This platform allows users to build and share their family trees, as well as access historical records and genealogy resources.\n3. FamilySearch: This is a free genealogy website that provides access to historical records and allows users to create and share their family trees.\n4. GenoPro: This is a professional genealogy software that allows users to create and publish their family trees online. It offers features such as customizable templates, multimedia integration, and collaboration tools.\n5. Legacy Family Tree: This is a popular genealogy software that offers a web-based platform for creating and sharing family trees. It includes features such as source citations, historical records access, and collaboration tools.\n6. Family Tree Maker: This is a genealogy software that offers a web-based platform for creating and sharing family trees. It includes features such as source citations, historical records access, and collaboration tools.\n7. We Relate: This is a collaborative genealogy platform that allows users to create and share their family trees, as well as connect with other researchers and share information.\n8. WikiTree: This is a free genealogy website that allows users to create and share their family trees, as well as collaborate with other researchers.\n9. Family Tree Builder: This is a free online genealogy platform that allows users to create and share their family trees, as well as access historical records and genealogy resources.\n10. Gramps: This is a free, open-source genealogy software that offers a web-based platform for creating and sharing family trees. It includes features such as customizable templates, multimedia integration, and collaboration tools."
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "llama-2-7b-chat-hf_response": "There are several curated databases available for spider-venom toxins, including:\n1. The Spider Toxin Database (STD): This database contains information on the structures, functions, and evolution of spider-venom toxins, including their mechanisms of action, pharmacological properties, and potential therapeutic applications.\n2. The Toxinology Database (ToxinDB): This database contains a comprehensive collection of toxins from various sources, including spiders, snakes, and scorpions. It includes information on the toxin structures, functions, and pharmacological properties, as well as their potential uses in medicine and biotechnology.\n3. The Venom-Toxin Database (ViTox): This database focuses specifically on venom-derived toxins, including spider-venom toxins. It contains information on the toxin structures, functions, and pharmacological properties, as well as their potential therapeutic applications and the species of origin.\n4. The Natural Products Database (NPDB): This database contains information on natural products, including spider-venom toxins, and their structures, functions, and pharmacological properties. It also includes information on the sources of these compounds and their potential therapeutic applications.\n5. The Toxinology Resource (ToxinologyR): This database provides a comprehensive collection of toxins, including spider-venom toxins, and their structural and functional information. It also includes tools for analyzing and predicting the properties of toxins, as well as a database of toxin-binding proteins.\nThese databases are valuable resources for researchers studying spider-venom toxins and their potential therapeutic applications, as they provide a centralized location for accessing and analyzing information on these compounds."
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "llama-2-7b-chat-hf_response": "Yes, Axitinib has been shown to prolong survival in patients with pancreatic cancer. In a phase III clinical trial known as the ALTERA study, Axitinib was compared to gemcitabine in patients with metastatic pancreatic cancer who had progressed after previous treatment. The results of the study, published in the New England Journal of Medicine in 2018, showed that Axitinib significantly improved overall survival compared to gemcitabine, with a median overall survival of 11.3 months in the Axitinib arm versus 9.2 months in the gemcitabine arm."
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "llama-2-7b-chat-hf_response": "MLP (Myosin Light Chain Phosphatase) regulates F-actin dynamics through its interaction with F-actin and other proteins, including the actin-binding protein cofilin. MLP dephosphorylates and inactivates cofilin, which leads to the depolymerization of F-actin filaments and the regulation of cellular processes such as cell migration, cell spreading, and cell signaling."
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "llama-2-7b-chat-hf_response": "Pseudokinases are proteins that have some characteristics of kinases but lack catalytic activity. The exact number of pseudokinases in the human kinome is not well established, as there is ongoing research and debate on their classification and definition. However, it is generally estimated that there are around 10-20 pseudokinases in the human kinome. These pseudokinases are often involved in various cellular processes, including cell signaling, cytoskeleton organization, and regulation of protein activity."
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "llama-2-7b-chat-hf_response": "ApoE mimetics are compounds that mimic the structure and function of apolipoprotein E (apoE), a protein involved in lipid metabolism and cholesterol transport. Here are three examples of apoE mimetics:\n1. ApoE-mimetic peptides: These are short peptides that mimic the structure of apoE and have been shown to have cholesterol-lowering and anti-inflammatory effects. Examples include peptides such as Gly-Ser-Thr-Ser-Leu-Gly-Gly-Gly (GSTSLEGG) and Gly-Ser-Thr-Ser-Leu-Gly-Gly-Ala (GSTSLELA).\n2. Small molecule apoE mimetics: These are synthetic compounds that mimic the structure of apoE and have been shown to have cholesterol-lowering and anti-inflammatory effects. Examples include compounds such as GW3965 and GW4869.\n3. ApoE-mimetic nanoparticles: These are nanoparticles that are designed to mimic the structure of apoE and have been shown to have cholesterol-lowering and anti-inflammatory effects. Examples include nanoparticles such as liposomes and polymer-based nanoparticles."
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "llama-2-7b-chat-hf_response": "SAMHD1 (Sperm-associated antigen 1) is an enzyme that plays a crucial role in the regulation of DNA damage response and immune function. There are sex differences in SAMHD1 activity, with studies suggesting that males and females have different levels of SAMHD1 expression and activity. Here are some of the sex differences in SAMHD1 activity that have been observed:\n1. Males have higher levels of SAMHD1 expression: Several studies have shown that males have higher levels of SAMHD1 expression compared to females, particularly in peripheral blood mononuclear cells (PBMCs) and other immune cells.\n2. Females are more susceptible to SAMHD1-mediated DNA damage: SAMHD1 has been shown to play a protective role in DNA damage response, but females are more susceptible to DNA damage and have a higher incidence of DNA damage-related disorders, such as cancer. This suggests that sex differences in SAMHD1 activity may play a role in these differences.\n3. SAMHD1 activity is regulated by sex hormones: Sex hormones, such as estrogen and testosterone, have been shown to regulate SAMHD1 expression and activity in various tissues, including the immune system. For example, estrogen has been shown to increase SAMHD1 expression in PBMCs, while testosterone has been shown to decrease SAMHD1 expression in the same cells.\n4. SAMHD1 activity is altered in sex-specific manner in response to toxins: Some studies have shown that sex-specific differences in SAMHD1 activity can be observed in response to exposure to certain toxins, such as dioxins and polycyclic aromatic hydrocarbons (PAHs). For example, dioxins have been shown to increase SAMHD1 activity in females, while PAHs have been shown to decrease SAMHD1 activity in both males and females.\n5. Sex differences in SAMHD1-mediated immune response: Sex differences in SAMHD1 activity have been observed in the context of immune responses, with males showing a more robust immune response to infection than females. This may be due in part to differences in SAMHD1 activity, which can influence the balance between pro"
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "llama-2-7b-chat-hf_response": "Yes, RUNX2 (RUNX2 transcription factor 1) has been shown to inhibit astrocyte differentiation. RUNX2 is a transcription factor that plays a crucial role in the regulation of cell fate decisions, including the differentiation of neural progenitor cells into astrocytes. Studies have shown that RUNX2 can repress the expression of genes involved in astrocyte differentiation and inhibit the process of astrocyte maturation."
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "llama-2-7b-chat-hf_response": "The Cobb-Stansby excision arthroplasty is a surgical procedure that is typically performed on the knee joint. It involves removing a portion of the damaged or arthritic joint cartilage and bone, and replacing it with an implant or prosthesis. The procedure is usually performed through a surgical incision on the knee, and may involve other techniques such as bone reshaping or ligament reconstruction to restore proper joint function."
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "llama-2-7b-chat-hf_response": "Yes, over-expression of GRHL2 has been shown to promote epithelial-to-mesenchymal transition (EMT) in various cell types, including cancer cells. EMT is a process by which epithelial cells lose their cell-cell adhesion and gain mesenchymal characteristics, such as increased migratory and invasive properties. GRHL2 has been shown to play a role in this process by modulating the expression of genes involved in EMT and by interacting with other transcription factors that promote EMT."
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "llama-2-7b-chat-hf_response": "T-UCRs (tumor-associated circular RNAs) have been implicated in lung cancer, including:\n1. Circular RNA 001 (circRNA001): upregulated in lung cancer tissues and cell lines, and promotes cell proliferation and migration.\n2. Circular RNA 1 (circRNA1): downregulated in lung cancer tissues and cell lines, and inhibits cell proliferation and migration.\n3. Circular RNA 2 (circRNA2): upregulated in lung cancer tissues and cell lines, and promotes cell proliferation and migration.\n4. Circular RNA 3 (circRNA3): upregulated in lung cancer tissues and cell lines, and inhibits cell proliferation and migration.\n5. Circular RNA 4 (circRNA4): downregulated in lung cancer tissues and cell lines, and inhibits cell proliferation and migration.\n6. Circular RNA 5 (circRNA5): upregulated in lung cancer tissues and cell lines, and promotes cell proliferation and migration.\n7. Circular RNA 6 (circRNA6): downregulated in lung cancer tissues and cell lines, and inhibits cell proliferation and migration.\n8. Circular RNA 7 (circRNA7): upregulated in lung cancer tissues and cell lines, and promotes cell proliferation and migration.\n9. Circular RNA 8 (circRNA8): downregulated in lung cancer tissues and cell lines, and inhibits cell proliferation and migration.\n10. Circular RNA 9 (circRNA9): upregulated in lung cancer tissues and cell lines, and promotes cell proliferation and migration.\n11. Circular RNA 10 (circRNA10): downregulated in lung cancer tissues and cell lines, and inhibits cell proliferation and migration.\nThese T-UCRs may serve as potential biomarkers or therapeutic targets for lung cancer diagnosis and treatment."
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "llama-2-7b-chat-hf_response": "GPR151 (G protein-coupled receptor 151) is an orphan receptor, meaning that it does not have a well-defined endogenous ligand or a clear physiological function. However, research has shown that GPR151 is involved in various cellular processes, including:\n1. Inflammation: GPR151 has been shown to play a role in the regulation of inflammation, with studies suggesting that it may act as an anti-inflammatory receptor.\n2. Cardiovascular health: GPR151 has been implicated in the regulation of blood pressure and the maintenance of vascular tone.\n3. Metabolism: GPR151 has been linked to the regulation of glucose and lipid metabolism, with studies suggesting that it may play a role in the development of metabolic disorders such as insulin resistance and type 2 diabetes.\n4. Neuroprotection: GPR151 has been shown to have neuroprotective effects, with studies suggesting that it may play a role in the protection of neurons against damage caused by oxidative stress and excitotoxicity.\n5. Cancer: GPR151 has been implicated in the development and progression of certain types of cancer, including breast, lung, and colon cancer.\nOverall, GPR151 is a complex receptor with a multifaceted role in various cellular processes, and further research is needed to fully understand its function and potential as a therapeutic target."
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "llama-2-7b-chat-hf_response": "The Fluzone Intradermal Quadrivalent vaccine contains the following attenuated live viruses:\n1. H1N1\n2. H3N2\n3. B/Victoria\n4. B/Yamagata\nNote: The Fluzone Intradermal Quadrivalent vaccine is approved for use in individuals 18 through 64 years of age. It is not approved for use in children younger than 18 years of age."
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "llama-2-7b-chat-hf_response": "The TNFR2 gene, also known as the Tumor Necrosis Factor Receptor 2 gene, has been genetically associated with Systemic Lupus Erythematosus (SLE). Specifically, mutations in the TNFR2 gene's promoter region have been identified as a risk factor for SLE."
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "llama-2-7b-chat-hf_response": "There is currently no licensed vaccine available for the prevention of peanut allergy. However, researchers are actively working on developing a vaccine for peanut allergy, and several promising candidates are in various stages of clinical trials. These vaccines aim to stimulate the immune system to produce allergy-fighting antibodies and reduce the risk of an allergic reaction to peanuts. While the development of a peanut allergy vaccine is promising, it is important to note that it may take several years before a vaccine becomes available for widespread use."
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "llama-2-7b-chat-hf_response": "The mouse Fxy gene is located on the X chromosome (Xp11.23)."
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "llama-2-7b-chat-hf_response": "MPE-seq is a method for sequencing DNA that is based on the use of a modified base analogue called methidiumpropyl-EDTA (methidiumpropyl-ethylene diamine tetraacetic acid, or MPE). MPE is a fluorescently labeled base analogue that can be incorporated into DNA during replication or repair processes, allowing for the detection and sequencing of specific DNA sequences.\nThe basis of the MPE-seq method is to use MPE as a label to mark specific regions of DNA, such as gene promoters or repetitive sequences, and then use next-generation sequencing (NGS) technologies to detect and sequence the labeled DNA regions. The MPE label allows for the selective enrichment of labeled DNA regions, which can improve the accuracy and throughput of the sequencing process.\nThe MPE-seq method typically involves the following steps:\n1. MPE labeling: The target DNA sequence is labeled with MPE using a modified DNA polymerase enzyme that incorporates MPE at specific regions of the DNA.\n2. Sequencing: The labeled DNA is then subjected to NGS technologies, such as Illumina or PacBio sequencing, to detect and sequence the MPE-labeled regions.\n3. Data analysis: The sequencing data is analyzed to identify the MPE-labeled regions and determine the sequence of the target DNA.\nMPE-seq has several advantages over traditional sequencing methods, including improved resolution, increased sensitivity, and reduced bias. It can be used to analyze a wide range of DNA sequences, including repetitive regions and gene promoters, and can be applied to a variety of biological samples, including whole genomes, transcriptomes, and epigenomes.\nIn summary, the basis of the MPE-seq method is to use a modified base analogue called MPE to label specific regions of DNA and then use NGS technologies to detect and sequence the labeled DNA regions. This allows for the selective enrichment of labeled DNA regions, which can improve the accuracy and throughput of the sequencing process."
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "llama-2-7b-chat-hf_response": "GWAR (Genome-Wide Association Study) is typically implemented using a variety of programming languages depending on the specific analysis and the research group involved. However, some common programming languages used for GWAR include:\n* R: R is a popular language for statistical computing and graphics, and is widely used in the field of genetics and genomics. Many GWAR studies use R for data analysis and visualization.\n* Python: Python is a versatile language that is widely used in bioinformatics and computational biology. Many GWAR studies use Python for data analysis, particularly for large-scale genomic data sets.\n* MATLAB: MATLAB is a high-level programming language that is commonly used in bioinformatics and computational biology for data analysis, visualization, and modeling. Some GWAR studies use MATLAB for data analysis and visualization.\n* SAS: SAS (Statistical Analysis System) is a software suite that is widely used in statistical analysis and data management. Some GWAR studies use SAS for data analysis and visualization.\nIt's worth noting that the choice of programming language may depend on the specific requirements of the study, the research question, and the availability of resources and expertise within the research group."
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "llama-2-7b-chat-hf_response": "Xaliproden (also known as verubecestat) is an oral small molecule inhibitor of the enzyme bromodomain-containing protein 4 (BRD4). There is currently limited evidence to suggest that xaliproden improves the prognosis of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.\nA phase 2 clinical trial conducted by the pharmaceutical company Biogen found that xaliproden did not meet the primary endpoint of slowing the progression of ALS in patients with early-stage disease. Specifically, the trial did not show a significant difference in the rate of decline in the ALS Functional Rating Scale (ALSFRS-R) between the xaliproden and placebo groups over a 24-week treatment period.\nHowever, the trial did reveal some interesting findings on the potential mechanisms of action of xaliproden in ALS. The study found that xaliproden increased the levels of a protein called TARDBP (tumor-associated protein 130kDa brain-specific) in the cerebrospinal fluid of ALS patients, which suggests that the drug may be targeting the underlying disease mechanisms.\nWhile the results of this trial were disappointing in terms of the primary endpoint, they provide valuable insights into the potential therapeutic effects of xaliproden in ALS and suggest that further research is warranted to fully understand its mechanism of action and potential as a treatment for this devastating disease."
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "llama-2-7b-chat-hf_response": "The LiPS-A3S line is a transgenic line in which the transgene is inserted into chromosome 16."
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "llama-2-7b-chat-hf_response": "There are several deep learning tools and models that can be used for predicting drug synergy, including:\n1. DeepDrug: This is a deep learning model that predicts drug synergy by analyzing the molecular structures of drugs and their targets. It uses a convolutional neural network (CNN) architecture to predict the binding affinity and synergy between drugs.\n2. Drug2gene: This is a deep learning model that predicts drug synergy by analyzing the gene expression profiles of drugs. It uses a random forest algorithm to identify the genes that are co-regulated by different drugs and predicts the synergy between them.\n3. DrugSynth: This is a deep learning model that predicts drug synergy by analyzing the chemical structures of drugs. It uses a graph convolutional neural network (GCNN) architecture to predict the molecular interactions between drugs and their targets.\n4. Synergizer: This is a deep learning model that predicts drug synergy by analyzing the genomic and transcriptomic profiles of drugs. It uses a combination of CNN and recurrent neural network (RNN) architectures to predict the synergy between drugs.\n5. DrugCombinator: This is a deep learning model that predicts drug synergy by analyzing the chemical structures of drugs and their targets. It uses a combination of CNN and RNN architectures to predict the interactions between drugs and their targets and predict the synergy between them.\n6. DrugNet: This is a deep learning model that predicts drug synergy by analyzing the protein-protein interaction networks of drugs. It uses a graph convolutional neural network (GCNN) architecture to predict the interactions between drugs and their targets and predict the synergy between them.\n7. DrugSynergyNet: This is a deep learning model that predicts drug synergy by analyzing the genomic and transcriptomic profiles of drugs. It uses a combination of CNN and RNN architectures to predict the synergy between drugs.\n8. DeepSynergy: This is a deep learning model that predicts drug synergy by analyzing the molecular structures of drugs and their targets. It uses a combination of CNN and RNN architectures to predict the interactions between drugs and their targets"
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "llama-2-7b-chat-hf_response": "The cloud-based platform that has been developed for comparing GWAS is called \"GWAS Central\". It is a web-based platform that allows researchers to upload and compare genome-wide association study (GWAS) data from different populations, and to identify genetic variants that are associated with the same trait or disease across different studies. GWAS Central was developed by the National Center for Biotechnology Information (NCBI) and is available for free use by researchers."
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "llama-2-7b-chat-hf_response": "Yes, CMB305 has been shown to be effective in treating sarcomas. CMB305 is a bispecific antibody that targets both CD3 and CD19, which are proteins found on the surface of T cells and B cells, respectively. By binding to these proteins, CMB305 can stimulate the immune system to attack cancer cells, including sarcomas.\nSarcomas are a type of cancer that originates in the connective tissue of the body, such as bone, cartilage, and fat. They can be difficult to treat and often have a poor prognosis, especially if they are aggressive or have spread to other parts of the body.\nStudies have shown that CMB305 can be effective in treating various types of sarcomas, including osteosarcoma, chondrosarcoma, and soft tissue sarcoma. For example, a phase 1 clinical trial published in the journal Cancer Research in 2017 found that CMB305 was well-tolerated and showed signs of anti-tumor activity in patients with advanced sarcomas.\nOverall, CMB305 is a promising immunotherapy approach for treating sarcomas, and further research is needed to fully understand its potential in this context."
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "llama-2-7b-chat-hf_response": "The Saint's Triad, also known as the Behçet's triad, is a set of three symptoms that are commonly seen in patients with Behçet's disease, a chronic inflammatory disorder that affects the blood vessels. The three manifestations of the Saint's Triad are:\n1. Uveitis: Inflammation of the uvea (the middle layer of the eye) is a common symptom of Behçet's disease. It can cause eye pain, redness, sensitivity to light, and blurred vision.\n2. Mucous membrane ulceration: Behçet's disease can cause ulcers to develop on the mucous membranes, including the mouth, nose, and genitals. These ulcers can be painful and can cause difficulty swallowing, breathing, or urinating.\n3. Arthritis: Behçet's disease can cause joint pain, swelling, and stiffness, similar to rheumatoid arthritis. The joints most commonly affected are those in the hands and feet.\nTogether, these three symptoms make up the Saint's Triad, which is often used to diagnose Behçet's disease. However, not everyone with Behçet's disease will develop all three symptoms, and some people may have additional symptoms not included in the triad."
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "llama-2-7b-chat-hf_response": "Yes, overexpression of LY6K has been associated with better prognosis for non-small cell lung cancer (NSCLC) patients. Studies have shown that high levels of LY6K expression are associated with improved overall survival, disease-free survival, and response to chemotherapy in NSCLC patients."
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "llama-2-7b-chat-hf_response": "Certainly! Here are some Cdk targets that are dephosphorylated during cytokinesis:\n1. Cyclin-dependent kinase 1 (Cdk1): Cdk1 is dephosphorylated at threonine 14 by the protein phosphatase Cdc25A during cytokinesis.\n2. Cyclin-dependent kinase 2 (Cdk2): Cdk2 is dephosphorylated at threonine 16 by the protein phosphatase Cdc25A during cytokinesis.\n3. Cyclin-dependent kinase 4 (Cdk4): Cdk4 is dephosphorylated at threonine 16 by the protein phosphatase Cdc25A during cytokinesis.\n4. Cyclin-dependent kinase 6 (Cdk6): Cdk6 is dephosphorylated at threonine 30 by the protein phosphatase Cdc25A during cytokinesis.\n5. Cyclin-dependent kinase 9 (Cdk9): Cdk9 is dephosphorylated at threonine 20 by the protein phosphatase Cdc25A during cytokinesis.\nThese dephosphorylation events are important for the proper progression of cytokinesis, as they allow the Cdks to interact with and activate their downstream targets, such as the microtubule-severing enzyme Ect2, and the actin-organizing protein APC."
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "llama-2-7b-chat-hf_response": "Xanamem is a drug that inhibits the activity of the enzyme glycogen synthase kinase-3 (GSK-3)."
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "llama-2-7b-chat-hf_response": "In yeast, the interaction between Hof1 and Cyk3 plays a crucial role in regulating the cellular response to oxidative stress. Hof1 is a transmembrane protein that functions as a sensor of oxidative stress, while Cyk3 is a protein kinase that regulates various cellular processes, including the DNA damage response. The interaction between Hof1 and Cyk3 leads to the activation of Cyk3 and the induction of genes involved in DNA repair and other stress-response pathways. This interaction helps to protect the cell against oxidative stress and maintain genome stability."
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "llama-2-7b-chat-hf_response": "T-bet (T-box transcription factor Eomesodermin) and Eomesodermin (Eomes) are T-UCRs that have been implicated in gastric cancer."
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "llama-2-7b-chat-hf_response": "The Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE), a chronic autoimmune disease that affects multiple organ systems. The LSI is a composite score that takes into account various clinical and laboratory parameters, including:\n1. Serologic markers (such as anti-nuclear antibodies and complement levels)\n2. Organ involvement (such as kidney, skin, and joint involvement)\n3. Disease activity (such as fever, fatigue, and pain)\n4. Functional status (such as physical and cognitive impairment)\nThe LSI is calculated by assigning scores to each of these parameters based on their severity, and then adding up these scores to obtain a total LSI score. The higher the LSI score, the more severe the disease. The LSI has been shown to be a useful tool for evaluating the severity of SLE and monitoring the effectiveness of treatment."
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "llama-2-7b-chat-hf_response": "ZSWIM6 is a gene that has been associated with several human disorders caused by de novo mutations, including:\n1. Neuromyelitis optica (NMO): A rare autoimmune disease that affects the central nervous system (CNS), including the optic nerves and spinal cord.\n2. Acute flaccid paralysis (AFP): A sudden onset of weakness or paralysis in one or more limbs, often accompanied by loss of sensation in the affected area.\n3. Spastic paraplegia: A type of paralysis that affects one or both legs, characterized by stiffness and spasms.\n4. Spastic paresis: A condition where there is a loss of muscle tone and weakness in one or more limbs, often accompanied by spasms and stiffness.\n5. Spinal muscular atrophy (SMA): A genetic disorder that affects the nerve cells (motor neurons) responsible for controlling voluntary muscle movement, leading to muscle weakness and wasting.\nThese disorders are caused by mutations in the ZSWIM6 gene, which codes for a protein involved in the regulation of intracellular signaling pathways and cytoskeleton organization. The mutations lead to dysfunction of the ZSWIM6 protein, which in turn disrupts the normal functioning of the affected signaling pathways and leads to the development of the associated disorders."
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "llama-2-7b-chat-hf_response": "The Koos Classification is used to classify diseases related to the nervous system, particularly those that affect the brain and spinal cord. Examples of diseases that can be classified using the Koos Classification include:\n1. Brain tumors\n2. Neurodegenerative disorders (e.g. Alzheimer's disease, Parkinson's disease, Huntington's disease)\n3. Stroke and cerebrovascular diseases\n4. Traumatic brain injuries\n5. Infections of the brain and meninges (e.g. meningitis, encephalitis)\n6. Demyelinating diseases (e.g. multiple sclerosis, neuromyelitis optica)\n7. Movement disorders (e.g. Parkinson's disease, dystonia)\n8. Seizure disorders (e.g. epilepsy)\n9. Sleep disorders (e.g. narcolepsy, insomnia)\n10. Psychiatric disorders (e.g. depression, anxiety)\nEach of these diseases is classified based on the specific symptoms and characteristics they exhibit, and the Koos Classification provides a standardized framework for organizing and understanding these conditions."
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "llama-2-7b-chat-hf_response": "AZD8601 is a potent and selective inhibitor of the enzyme PI3K (phosphatidylinositol 3-kinase). In vivo, AZD8601 has been shown to have a variety of effects, including:\n1. Inhibition of tumor growth: AZD8601 has been shown to inhibit the growth of various types of tumors, including breast, lung, and colon cancer, both in vitro and in vivo.\n2. Inhibition of angiogenesis: AZD8601 has been shown to inhibit the formation of new blood vessels, a process known as angiogenesis, which is necessary for tumor growth and metastasis.\n3. Enhancement of chemotherapy: AZD8601 has been shown to enhance the effectiveness of certain chemotherapeutic agents, such as paclitaxel, in treating cancer.\n4. Immune modulation: AZD8601 has been shown to modulate the immune response, including the activation of immune cells and the production of cytokines.\n5. Anti-inflammatory effects: AZD8601 has been shown to have anti-inflammatory effects in various models of inflammation, including colitis and arthritis.\n6. Neuroprotection: AZD8601 has been shown to have neuroprotective effects in various models of neurodegeneration, including Alzheimer's disease and Parkinson's disease.\n7. Cardiovascular protection: AZD8601 has been shown to have cardiovascular protective effects in various models of cardiovascular disease, including hypertension and atherosclerosis.\n8. Anti-aging effects: AZD8601 has been shown to have anti-aging effects in various models of aging, including delayed aging in mice.\nIt is important to note that these effects are based on studies in cell cultures and animal models, and more research is needed to determine the efficacy and safety of AZD8601 in humans."
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "llama-2-7b-chat-hf_response": "SAHFs (Sperm Associated Histone Fragments) are created through a process called histone fragmentation, which involves the degradation of histone proteins in the sperm nucleus during the process of spermatogenesis. This process is mediated by enzymes called histone-specific proteases, which break down the histone proteins into smaller fragments. The resulting fragments are then packaged into the sperm nucleus, where they play a role in the regulation of gene expression during fertilization."
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "llama-2-7b-chat-hf_response": "The PDZ (PSD-95/Discs-large/ZO-1) domain is a protein-binding module found in the SATB1 protein. The PDZ domain of SATB1 plays a crucial role in the regulation of its localization and function by interacting with other proteins and cytoskeletal elements. In particular, the PDZ domain of SATB1 can bind to the cytoplasmic tail of the Notch receptor and other transmembrane proteins, which helps to regulate the activity of the Notch signaling pathway."
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "llama-2-7b-chat-hf_response": "BLISS (Block, Lift, Increment, Shrink, and Shift) is a statistical technique used to estimate the effect of a treatment or intervention on an outcome variable in the presence of confounding variables. It is based on the idea of creating a comparison group that is similar to the treatment group in all observed characteristics except for the treatment itself.\nThe BLISS technique involves the following steps:\n1. Block: Divide the data into blocks based on the confounding variables.\n2. Lift: Create a lift sample for each block, which is a sample of observations that are similar to the treatment group in all observed characteristics except for the treatment.\n3. Increment: Increment the lift sample by a small amount to create a comparison group.\n4. Shrink: Shrink the lift sample back to the original sample size.\n5. Shift: Shift the comparison group by the amount of the treatment effect.\nThe BLISS technique can be used to estimate the effect of a treatment on an outcome variable in the presence of confounding variables, while also accounting for the correlation between the confounding variables and the treatment. It is a useful technique in causal inference and can be used in a variety of applications, including observational studies and randomized controlled trials."
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "llama-2-7b-chat-hf_response": "Here are three known NK3R (neurokinin receptor 3) antagonists:\n1. A-83-01: A potent and selective NK3R antagonist that has been shown to have anti-inflammatory effects in various animal models.\n2. GR 127935: A highly selective and potent NK3R antagonist that has been shown to have potential in the treatment of inflammatory disorders such as asthma and allergic rhinitis.\n3. MK-0599: A novel, orally available NK3R antagonist that has been shown to have anti-inflammatory effects in various animal models, including models of asthma and atopic dermatitis."
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "llama-2-7b-chat-hf_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is called BMS-986177."
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "llama-2-7b-chat-hf_response": "Vaxchora, a cholera vaccine, has been shown to provide protection against moderate to severe cholera in clinical trials. The protective efficacy of Vaxchora against moderate to severe cholera has been estimated to be around 80-90% in adults and 60-70% in children, based on the results of clinical trials conducted in endemic areas. However, it's important to note that no vaccine can provide 100% protection against cholera, and the duration of protection may vary depending on several factors, including the strain of the bacteria, the individual's immune response, and the overall health of the individual."
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "llama-2-7b-chat-hf_response": "The first cholera vaccine approved in the US was the oral cholera vaccine, also known as the \"Live, Attenuated, Oral Cholera Vaccine\" (LAV), which was approved by the US Food and Drug Administration (FDA) in 1989."
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "llama-2-7b-chat-hf_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is mutations in the X-linked gene encoding the protein CD40 ligand (CD40L). CD40L is a co-stimulatory molecule that plays a critical role in the activation and differentiation of B cells, and mutations in the CD40L gene can lead to a range of immunological defects, including CVID."
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "llama-2-7b-chat-hf_response": "The IFIT1 gene has been shown to play a role in the development and progression of Systemic Lupus Erythematosus (SLE), an autoimmune disease characterized by the production of autoantibodies and inflammation in multiple organ systems. Studies have found that IFIT1 is a negative regulator of type I interferons (IFN-α/β), which are key players in the immune response to infection and inflammation. In SLE patients, the IFIT1 gene is often mutated or downregulated, leading to an imbalance in the immune response and the production of excessive amounts of IFN-α/β. This can contribute to the development of autoantibodies and the progression of SLE flares."
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "llama-2-7b-chat-hf_response": "The Liverpool Elbow Score (LES) is a patient-reported outcome measure used to assess the severity of elbow symptoms and disability in patients with elbow problems, such as tennis elbow (lateral epicondylitis) or golfer's elbow (medial epicondylitis). The score is used to evaluate the effectiveness of treatments for these conditions and to monitor progress over time. The LES consists of 10 questions that assess the severity of symptoms such as pain, stiffness, and weakness in the elbow, as well as the impact of these symptoms on daily activities. The score ranges from 0 to 100, with higher scores indicating greater severity of symptoms and disability."
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "llama-2-7b-chat-hf_response": "The 100,000 Genomes Project is a large-scale genomics initiative launched in the UK in 2012 to accelerate the understanding of genetic variation and its role in disease. As part of this project, efforts have been made to investigate the genomics of sarcoma, a rare and complex cancer type that affects connective tissue. Here are some key findings and insights from the 100,000 Genomes Project related to sarcoma:\n1. High genomic diversity: Sarcomas are known to be genetically heterogeneous, and the 100,000 Genomes Project has confirmed this by identifying a high level of genomic diversity among sarcoma tumors. This diversity is thought to be due to the complex genetic mutations that occur in these tumors.\n2. Frequent mutations in genes involved in DNA damage response: The 100,000 Genomes Project has identified a number of genes that are frequently mutated in sarcomas, including genes involved in the DNA damage response pathway, such as ATM, ATR, and BRCA1. These mutations may contribute to the development and progression of sarcomas.\n3. Mutations in KRAS and other RTK signaling pathway genes: The 100,000 Genomes Project has also identified mutations in genes involved in the RTK (receptor tyrosine kinase) signaling pathway, such as KRAS, in a subset of sarcomas. These mutations are thought to play a role in the development and progression of these tumors.\n4. Identification of new sarcoma subtypes: The 100,000 Genomes Project has helped to identify new subtypes of sarcomas based on the genomic alterations present in these tumors. For example, the project has identified a subtype of sarcoma called \"clear cell sarcoma of soft tissue,\" which is characterized by a specific set of genomic alterations.\n5. Improved understanding of the molecular mechanisms underlying sarcoma development and progression: The 100,000 Genomes Project has provided valuable insights into the molecular mechanisms underlying the development"
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "llama-2-7b-chat-hf_response": "Yes, protein ALEX1 contains multiple armadillo (ARM) repeats."
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "llama-2-7b-chat-hf_response": "There are several enzymes that remove histone modifications. Here are some examples:\n1. Histone demethylases: These enzymes remove methyl groups from histone proteins, leading to changes in chromatin structure and gene expression. Examples of histone demethylases include KDM4B, KDM5, and KDM1A.\n2. Histone acetyltransferases: These enzymes add acetyl groups to histone proteins, leading to changes in chromatin structure and gene expression. Examples of histone acetyltransferases include CBP (CREB-binding protein) and p300.\n3. Histone deacetylases: These enzymes remove acetyl groups from histone proteins, leading to changes in chromatin structure and gene expression. Examples of histone deacetylases include HDAC1, HDAC2, and HDAC3.\n4. Histone ubiquitin ligases: These enzymes remove histone proteins from chromatin, leading to changes in chromatin structure and gene expression. Examples of histone ubiquitin ligases include RNF2 and RNF4.\n5. Histone phosphatases: These enzymes remove phosphate groups from histone proteins, leading to changes in chromatin structure and gene expression. Examples of histone phosphatases include PP1 and PP2A.\nThese enzymes play important roles in regulating chromatin structure and gene expression, and their dysregulation has been implicated in various diseases, including cancer and neurological disorders."
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "llama-2-7b-chat-hf_response": "Head CT scans do not increase the risk of brain tumors. While there is some concern that repeated exposure to radiation from CT scans may increase the risk of cancer, the risk associated with a single head CT scan is considered to be very low.\nThe American College of Radiology recommends that patients receive a CT scan only when the potential benefit of the scan outweighs the small risk of radiation exposure. Additionally, the use of advanced imaging techniques, such as MRI or PET scans, may reduce the need for repeated CT scans and further minimize the risk of radiation exposure.\nIt is important to note that while head CT scans do not increase the risk of brain tumors, they can help identify potential brain abnormalities, such as tumors or cerebral edema, which can be treated to improve outcomes."
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "llama-2-7b-chat-hf_response": "Otx2 is associated with neural pluripotency."
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "llama-2-7b-chat-hf_response": "The murine beta globin locus region has 11 DNaseI hypersensitive sites (DHS)."
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "llama-2-7b-chat-hf_response": "Here are some European influenza vaccines that are currently available or have been approved in the past:\n1. Fluarix Tetra (GlaxoSmithKline): This is a quadrivalent vaccine that protects against four strains of the influenza virus (two A strains and two B strains).\n2. Fluvirin (Novartis): This is a trivalent vaccine that protects against three strains of the influenza virus (two A strains and one B strain).\n3. Aggripulse (GlaxoSmithKline): This is a quadrivalent vaccine that protects against four strains of the influenza virus (two A strains and two B strains).\n4. Fluad (GlaxoSmithKline): This is a quadrivalent vaccine that protects against four strains of the influenza virus (two A strains and two B strains). It is specifically designed for adults aged 65 years and older.\n5. Focetria (Sanofi Pasteur): This is a trivalent vaccine that protects against three strains of the influenza virus (two A strains and one B strain).\n6. Flublok (Protein Sciences): This is a trivalent vaccine that protects against three strains of the influenza virus (two A strains and one B strain). It is made using an insect cell-based production process.\n7. FluMist (AstraZeneca): This is a quadrivalent vaccine that protects against four strains of the influenza virus (two A strains and two B strains). It is administered as a nasal spray.\n8. Agrippal (Novartis): This is a quadrivalent vaccine that protects against four strains of the influenza virus (two A strains and two B strains). It is specifically designed for children and adolescents.\n9. Fluarix (GlaxoSmithKline): This is a trivalent vaccine that protects against three strains of the influenza virus (two A strains and one B strain). It is specifically designed for children and adolescents.\n10. Vaxigrip (Sanofi"
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "llama-2-7b-chat-hf_response": "Yes, the Paramyxovirus geneome is segmented, negative-sense RNA. Paramyxoviruses are a family of viruses that include the viruses that cause measles, mumps, and respiratory diseases, among others. Their genome consists of several segments of negative-sense RNA, which are transcribed in the opposite direction to the direction of transcription, resulting in a complementary RNA molecule."
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "llama-2-7b-chat-hf_response": "Roflumilast cream is effective for the treatment of plaque psoriasis."
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "llama-2-7b-chat-hf_response": "Several tools have been developed for identifying and visualizing non-coding RNA (ncRNA) promoters. Here are some of the commonly used tools:\n1. PROMoter Finder: This tool uses a Bayesian approach to predict the location of ncRNA promoters in the genome. It can be used to identify both known and novel ncRNAs.\n2. CpG Island Finder: This tool identifies regions of the genome that are enriched in the dinucleotide CpG, which is often associated with ncRNA promoters.\n3. RNApromoter: This tool uses a combination of sequence and functional data to predict the location of ncRNA promoters. It can also be used to predict the expression level of ncRNAs.\n4. NCRNApromoter: This tool uses a machine learning approach to predict the location of ncRNA promoters in the genome. It can be used to identify both known and novel ncRNAs.\n5. DeepSEA: This tool uses a deep learning approach to predict the location of ncRNA promoters in the genome. It can be used to identify both known and novel ncRNAs.\n6. RNAPro: This tool uses a combination of sequence and functional data to predict the location of ncRNA promoters. It can also be used to predict the expression level of ncRNAs.\n7. NCRNApromoter2: This tool is an updated version of the NCRNApromoter tool, which uses a more advanced machine learning algorithm to predict the location of ncRNA promoters.\n8. RNApromoter2: This tool is an updated version of the RNApromoter tool, which uses a more advanced machine learning algorithm to predict the location of ncRNA promoters.\nThese are some of the commonly used tools for identifying and visualizing ncRNA promoters. Each tool has its own strengths and limitations, and the choice of tool will depend on the specific research question and experimental design."
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "llama-2-7b-chat-hf_response": "SWIM (Splicing Workbench for Integrative Modeling) is a tool that can be used to identify genes that are differentially spliced between two or more sample groups, such as healthy tissue and glioblastoma. Here are some examples of genes that SWIM has identified as down-regulated in glioblastoma:\n1. KRAS (Kirsten rat sarcoma viral oncogene homolog): KRAS is a gene that encodes a protein involved in cell signaling pathways. SWIM analysis has identified several splicing variants of KRAS that are down-regulated in glioblastoma.\n2. BRAF (v-raf murine sarcoma viral oncogene homolog 1): BRAF is a gene that encodes a protein involved in cell signaling pathways. SWIM analysis has identified several splicing variants of BRAF that are down-regulated in glioblastoma.\n3. PTEN (phosphatase and tensin homolog): PTEN is a gene that encodes a protein involved in cell signaling pathways. SWIM analysis has identified several splicing variants of PTEN that are down-regulated in glioblastoma.\n4. TP53 (tumor protein p53): TP53 is a gene that encodes a protein involved in cell cycle regulation and DNA repair. SWIM analysis has identified several splicing variants of TP53 that are down-regulated in glioblastoma.\n5. CDKN2A (cyclin-dependent kinase inhibitor 2A): CDKN2A is a gene that encodes a protein involved in cell cycle regulation. SWIM analysis has identified several splicing variants of CDKN2A that are down-regulated in glioblastoma.\n6. SLC9A2 (solute carrier family 9, subfamily A, member 2): SLC9A2 is a gene that encodes a protein involved in drug transport. SWIM analysis has identified several splicing variants of SLC9A2 that are down-regulated in glioblastoma.\n7. GSTP1 (glutathione S-transferase P1): GSTP1 is a gene that encodes a"
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "llama-2-7b-chat-hf_response": "Several R packages have been developed for studying Topological Associated Domains (TADs), including:\n1. TADb: This package provides a comprehensive framework for the analysis of TADs, including the ability to identify TADs from ChIP-seq data, and to quantify the degree of association between TADs and various genomic features.\n2. TADtrack: This package provides a tool for identifying TADs in ChIP-seq data, as well as for visualizing the spatial organization of TADs in the genome.\n3. TADfinder: This package provides a comprehensive toolkit for identifying and characterizing TADs, including the ability to integrate TAD information with other genomic data, such as gene expression and histone modification data.\n4. TopoTool: This package provides a set of tools for the analysis of topological associating domains (TADs) in 3D chromatin structures.\n5. ChromHMM: This package provides a probabilistic model for the organization of chromatin into TADs, and can be used to infer the 3D structure of chromatin from ChIP-seq data.\n6. TADtrackR: This package provides a tool for identifying TADs in ChIP-seq data, as well as for visualizing the spatial organization of TADs in the genome.\n7. TAD-seq: This package provides a tool for identifying TADs in ChIP-seq data, as well as for quantifying the degree of association between TADs and various genomic features.\n8. TAD-genome: This package provides a tool for identifying TADs in ChIP-seq data, as well as for visualizing the spatial organization of TADs in the genome.\n9. TAD-seq-2: This package provides a tool for identifying TADs in ChIP-seq data, as well as for quantifying the degree of association between TADs and various genomic features.\n10. TAD-seq-3: This package provides a tool for identifying TADs in ChIP-seq data, as well as for visualizing the spatial organization of TADs in the genome.\nThese packages provide a range of tools and methods for studying TADs, including the ability to identify TADs from ChIP-seq"
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "llama-2-7b-chat-hf_response": "The BioConductor tool developed for accessing bacterial regulatory networks is called \"BioCyc\"."
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "llama-2-7b-chat-hf_response": "The end products of the shikimate pathway are:\n1. Aromatic amino acids: phenylalanine, tyrosine, and tryptophan\n2. Quinones: ubiquinone (coenzyme Q) and menaquinone (vitamin K2)\n3. Chlorophyll: chlorophyll a and chlorophyll b\n4. Flavonoids: anthocyanins, flavonols, and isoflavonoids\n5. Carotenoids: beta-carotene, lycopene, and lutein\n6. Alkaloids: nicotine, caffeine, and morphine\n7. Tannins: ellagic acid and gallic acid\nThese end products are important for various physiological processes, including photosynthesis, antioxidant defense, and signal transduction."
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "llama-2-7b-chat-hf_response": "Yes, cabergoline is sometimes used to treat Nelson's syndrome, which is a rare condition that occurs after surgical removal of a pituitary tumor. Cabergoline is a dopamine receptor agonist that can help to reduce the growth of the remaining pituitary tissue and alleviate symptoms such as excessive growth hormone secretion, prolactin secretion, and visual disturbances. However, it is important to note that cabergoline is not a cure for Nelson's syndrome, and other treatments such as radiation therapy may also be necessary to control the growth of the remaining pituitary tissue."
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "llama-2-7b-chat-hf_response": "Liebenberg syndrome is a rare genetic disorder that affects the nervous system and is characterized by the following main manifestations:\n1. Progressive weakness and wasting of the muscles, particularly those of the face, arms, and legs.\n2. Impaired coordination and balance, leading to difficulty with walking and maintaining posture.\n3. Gradual loss of vision, including loss of peripheral vision and eventual blindness.\n4. Cognitive decline and impaired memory.\n5. Seizures, which can be severe and frequent.\n6. Sleep disturbances, including excessive daytime sleepiness and difficulty initiating sleep.\n7. Hearing loss, particularly high-frequency hearing loss.\n8. Abnormalities in the structure and function of the heart, including abnormal heart rhythms and decreased heart function.\nThese manifestations typically appear in infancy or early childhood and can have a significant impact on an individual's quality of life."
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "llama-2-7b-chat-hf_response": "There are several orally bioavailable MPS1 kinase inhibitors that have been identified and developed for the treatment of various diseases, including cancer. Here are some examples:\n1. Vorinostat (Zolinza): Vorinostat is an oral histone deacetylase (HDAC) inhibitor that has been shown to inhibit MPS1 kinase activity and is approved for the treatment of cutaneous T-cell lymphoma.\n2. Romidepsin (Istodax): Romidepsin is an oral HDAC inhibitor that has been shown to inhibit MPS1 kinase activity and is approved for the treatment of cutaneous T-cell lymphoma.\n3. Panobinostat (Farydak): Panobinostat is an oral inhibitor of the enzyme PI3K (phosphatidylinositol 3-kinase), which is downstream of MPS1 kinase. It is approved for the treatment of multiple myeloma.\n4. GDC-0980 (GDC-0980): GDC-0980 is an oral inhibitor of the PI3K/Akt signaling pathway, which is downstream of MPS1 kinase. It is being developed for the treatment of various cancers, including breast, lung, and ovarian cancer.\n5. BAY 80-6946: BAY 80-6946 is an oral inhibitor of the PI3K/Akt signaling pathway, which is downstream of MPS1 kinase. It is being developed for the treatment of various cancers, including breast, lung, and ovarian cancer.\n6. AZD-2850: AZD-2850 is an oral inhibitor of the PI3K/Akt signaling pathway, which is downstream of MPS1 kinase. It is being developed for the treatment of various cancers, including breast, lung, and ovarian cancer.\n7. PF-04490153: PF-04490153 is an oral inhibitor of the PI3K/A"
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "llama-2-7b-chat-hf_response": "Yes, golimumab, a tumor necrosis factor-alpha (TNF-alpha) inhibitor, has been studied for the treatment of diabetes. Golimumab has been shown to improve glycemic control and reduce the frequency of severe hypoglycemic events in patients with type 1 diabetes and type 2 diabetes. However, it is not FDA-approved for the treatment of diabetes."
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "llama-2-7b-chat-hf_response": "Yes, progeria, also known as Hutchinson-Gilford progeria syndrome (HGPS), is caused by an autosomal recessive mutation in the LMNA gene. This gene encodes for the protein lamin A, which is involved in the structure and function of the nuclear lamina, a network of filaments that provides mechanical support to the nucleus and regulates various cellular processes. Mutations in the LMNA gene lead to a deficiency of functional lamin A, which results in the characteristic features of progeria, including accelerated aging and a shortened lifespan."
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "llama-2-7b-chat-hf_response": "Variants at 12q14 and 12q24 have been associated with several common diseases and conditions, including:\n12q14:\n* Bipolar disorder: Several genetic variants at 12q14 have been associated with an increased risk of developing bipolar disorder.\n* Schizophrenia: Some studies have found an increased risk of schizophrenia in individuals with genetic variants at 12q14.\n* Major depressive disorder: Variants at 12q14 have been linked to an increased risk of major depressive disorder.\n* Autism spectrum disorder: Some studies have found an increased risk of autism spectrum disorder in individuals with genetic variants at 12q14.\n12q24:\n* Prostate cancer: Variants at 12q24 have been associated with an increased risk of developing prostate cancer.\n* Breast cancer: Some studies have found an increased risk of breast cancer in individuals with genetic variants at 12q24.\n* Ovarian cancer: Variants at 12q24 have been linked to an increased risk of ovarian cancer.\n* Colorectal cancer: Some studies have found an increased risk of colorectal cancer in individuals with genetic variants at 12q24.\nIt's important to note that the association between these variants and these diseases is complex and not fully understood, and more research is needed to determine the exact mechanisms by which these variants contribute to disease risk."
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "llama-2-7b-chat-hf_response": "The ligands of the Roundabout (Robo) receptors are the Robo ligands, which are a family of secreted proteins that bind to and activate Robo receptors. The specific Robo ligands include:\n* Robo1 ligand (RALBP1)\n* Robo2 ligand (RALBP2)\n* Robo3 ligand (RALBP3)\n* Robo4 ligand (RALBP4)\nThese ligands are involved in regulating the migration and axon guidance of neurons during development and in the maintenance of neural circuits."
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "llama-2-7b-chat-hf_response": "Yes, TFII-I has been shown to play a role in megakaryopoiesis, the process of developing megakaryocytes (blood cells that give rise to platelets) from hematopoietic stem cells. TFII-I is a transcription factor that is involved in the regulation of gene expression, particularly in the context of hematopoiesis. Studies have shown that TFII-I is required for the proper differentiation of megakaryocytes and the maintenance of platelet function. Specifically, TFII-I regulates the expression of genes involved in platelet-specific functions such as platelet membrane protein expression and secretion."
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "llama-2-7b-chat-hf_response": "Yes, atenolol is metabolized by the cytochrome P450 enzyme CYP2D6. CYP2D6 is responsible for the metabolism of approximately 20-30% of atenolol, and the metabolism of the drug is a major determinant of its pharmacokinetics and pharmacodynamics. Individuals with a functional CYP2D6 gene tend to have higher levels of atenolol in their bodies and may experience greater side effects compared to those with a non-functional CYP2D6 gene."
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "llama-2-7b-chat-hf_response": "ExpansionHunter is a tool used for the detection of gene fusion events in cancer genomes. Here are some versions of ExpansionHunter:\n1. ExpansionHunter 1.0: This was the initial release of the tool, which could detect gene fusions in RNA-seq data.\n2. ExpansionHunter 2.0: This version improved the accuracy of gene fusion detection and introduced a new algorithm for identifying fusions in DNA sequencing data.\n3. ExpansionHunter 2.1: This update added new features, including the ability to detect gene fusions in single-cell RNA-seq data and improved performance in detecting fusions in low-coverage data.\n4. ExpansionHunter 3.0: This version introduced a new algorithm for detecting gene fusions in DNA sequencing data, which improved the accuracy and speed of the analysis.\n5. ExpansionHunter 3.1: This update added new features, including the ability to detect gene fusions in circular RNA transcripts and improved performance in detecting fusions in RNA-seq data with high levels of repetitive sequences.\n6. ExpansionHunter 4.0: This version introduced a new algorithm for detecting gene fusions in DNA sequencing data, which improved the accuracy and speed of the analysis.\n7. ExpansionHunter 4.1: This update added new features, including the ability to detect gene fusions in single-molecule real-time sequencing data and improved performance in detecting fusions in RNA-seq data with high levels of repetitive sequences.\n8. ExpansionHunter 5.0: This version introduced a new algorithm for detecting gene fusions in DNA sequencing data, which improved the accuracy and speed of the analysis.\n9. ExpansionHunter 5.1: This update added new features, including the ability to detect gene fusions in single-cell RNA-seq data and improved performance in detecting fusions in RNA-seq data with high levels of repetitive sequences.\n10. ExpansionHunter 6.0: This version introduced a new algorithm for detecting gene fusions in DNA sequencing data, which improved the accuracy and speed of the analysis.\nNote that the versions of ExpansionHunter may have different features, improvements, and bug fixes, so it's worth"
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "llama-2-7b-chat-hf_response": "Adamts18 (a disintegrin and metalloproteinase domain-containing protein 18) plays a role in regulating hormone receptor signaling by modulating the activity of hormone receptors and their downstream signaling pathways. Specifically, Adamts18 has been shown to interact with and inhibit the activity of estrogen receptors (ERs), leading to reduced activation of downstream signaling pathways in response to estrogen. This suggests that Adamts18 may play a role in regulating hormone-sensitive processes, such as cell proliferation, differentiation, and survival, in response to hormone signaling."
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "llama-2-7b-chat-hf_response": "Thiazovivin is a small molecule inhibitor of the enzyme p300/CBP-associated factor (PCAF), which is involved in the regulation of various cellular processes, including gene expression, cell proliferation, and differentiation. Thiazovivin works by binding to the active site of PCAF and preventing it from catalyzing the acetylation of histones and other proteins, leading to changes in chromatin structure and gene expression. This can result in the inhibition of the expression of genes involved in cell proliferation and survival, leading to the death of cancer cells."
  }
]